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Abstract
The discovery and use of fluorescent proteins has been of extreme importance
in biological imaging of cells, tissues, and organs. In order to address some of the
limitations of fluorescent tags, second harmonic generation can be used. Second har-
monic generating nanoprobes allow nontoxic, long-term imaging that, with proper
functionalization, can be utilized for biological imaging applications. As a proof of
principle, commercial tetragonal barium titanate nanoparticles were functionalized
to expose surface amine groups, which could be further modified for a plethora of
biological applications. Barium titanate nanoparticles were functionalized for selec-
tive targeting of tissue sections, biorthogonal linkages and for nonspecific long-term
imaging using biocompatible polymers enabling the study of cells as they differentiate
during zebrafish development. Since the commercial barium titanate nanoparticles do
not have a narrow size distribution, which limits the application of such nanoprobes,
synthesis of monodisperse nanocrystals was attempted.
Zinc oxide nanocrystals were synthesized by solvothermal methods involving the
base hydrolysis of zinc salts in the presence of capping ligands. Different synthesis
procedures were investigated based on the properties of the prepared nanoparticles.
To prevent nanoparticle aggregation and to achieve good dispersion, a capping agent
was chosen that provides a tightly bound shell around the nanoparticles. It was
observed that the polymerization of PEG molecules with the organic ligands bound
to the surface of zinc oxide provided the most adequate coating for the desired size
control and dispersion of the nanocrystals. Exploration of the experimental conditions
enabled production of variable size hexagonal zinc oxide nanocrystals, which can be
vii
used both as SHG probes and as quantum dots.
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1Chapter 1
Introduction
1.1 Biological Imaging Challenges
In order to gain a better understanding of the organization of biological struc-
tures and mechanisms that govern them at cellular and subcellular levels, we resort
to microscopy. Ideally, we need to visualize the biological specimen in its native
physiological state which can be done by in vivo imaging. To image an object in the
microscope, illumination radiation interacts with the specimen in order to generate
contrast and produce two-dimensional images. The various imaging technologies dif-
fer in five main aspects: resolution, penetration depth, energy expended for image
generation (ionizing vs. nonionizing), availability of injectable, biocompatible molec-
ular probes, and the detection threshold for a given technology [1, 2]. Among the
variety of noninvasive imaging approaches, biological sample imaging, both in vivo
and in vitro, has relied on light microscopy with fluorescence microscopy emerging as
one of the most powerful imaging techniques [3].
In fluorescence microscopy, fluorescent probes are used for the purpose of contrast
enhancement. One of the major benefits of fluorescence imaging is the availability
of a large variety of imaging contrast agents, some of which are endogenous (e.g.,
keratin, elastin, retinol, etc.) while others are exogenous (e.g., fluorescein, rhodamin,
AlexaFluor dyes, quantum dots, etc.). The plethora of biocompatible, commercially
available fluorescent probes enables tuning of the penetration depth, and signal in-
2tensity, as well as the method of introduction into the organism. Some fluorescent
probes are genetically encodable (e.g., green fluorescent protein (GFP) and its vari-
eties, etc.), while others need to be injected into or uptaken by the organism (e.g.,
inorganic dyes, quantum dots, etc.). In addition to aiding visualization, functional
fluorescent probes provide dynamic information regarding localization and quantity
of target molecules [4]. This enables in vivo fluorescence imaging to have many ap-
plication, one of which is in the cancer detection: utilized in identification of tumor
boundaries (aiding the efficiency of cancer treatment), assessment of blood and lymph
vessels, and monitoring treatment progress [5]. It can also aid in the understanding
of an organisms' development through different stages and in detection of any malfor-
mations during that time. Fluorescent probes can also be used as sensors to measure
the concentration of calcium, hydrogen, and other ions and molecules along with the
detection of membrane voltages [6, 7].
However, in vivo imaging of biological samples is technically a very challenging
task due to mainly two reasons. Thick and opaque tissue samples tend to absorb and
scatter photons and generate strong autofluorescence, which decreases the signal-to-
noise ratio (SNR) and makes it difficult to detect and quantify the desired signal.
Secondly, imaging in biological environments requires the imaging agent to be stable,
biocompatible, and to accumulate with specificity at the desired target position [8].
One way to address the fundamental barriers of tissue imaging, mainly absorption
and scattering of photons by the tissue, is to utilize low energy near infrared (NIR)
light sources. As photons travel through the tissue and interact with it, their trajec-
tories will depend on the tissue absorptivity and its scattering properties [9, 1]. The
total light absorption will be proportional to the absorption coefficients and the molar
concentration of all the components of the tissue. As photons are absorbed, there is
a possibility that they would be emitted as fluorescent light in a process called aut-
ofluorescence. Unwanted autofluorescence lowers the SNR and can be avoided with
the use of filters or careful selection of excitation wavelength. In most tissues the
major absorbers are water and hemoglobin [10], with the lowest absorptions observed
in the 650-900 nm region (see figure 1.1) [3, 1]. Therefore, photon absorption can be
3Figure 1.1: Absorbance of most common tissue absorbers, hemoglobin (Hb), oxy-
genated hemoglobin (HbO2) and water, as a function of excitation wavelength. Se-
lecting excitation wavelengths in the NIR range is beneficial, as the absorption of
tissue is at a minimum from 650 to 900 nm [1]. The deepest penetration inside the
tissue with minimal effects on the organism can be achieved utilizing NIR light and
as such is desirable for biological imaging purposes. (The source of this image is [1].)
minimized utilizing low-energy light sources within the NIR region; leading to longer
tissue penetration depth, on the order of centimeters [1].
In addition to photon absorption, photon scattering disrupts tissue imaging. The
size of the tissue or cellular components with respect to the wavelength of light,
and the refractive index difference between the scattering particle and the medium
determine the scattering properties [11]. In the NIR region, cellular components have
dimensions similar to the incoming wavelength of light, and their refractive indices
are similar, thus NIR light will be mostly forward-directed, enabling deeper tissue
penetration [2, 11].
Therefore, useful in vivo imaging probes should interact with low energy NIR light
to ensure deeper penetration length, as well as minimal deleterious effects on both
the imaging probe and the surrounding organism. In addition, the probe itself should
be stable in the cellular environment and elicit no immunological response by the
organism. To ensure that the probe is biocompatible and also has the appropriate
functionality, the imaging probe can be coated with ligands that impart the desired
effects. In the following sections, the most commonly used imaging probes will be
4Figure 1.2: Jablonski energy diagram illustrating the electronic states of a molecule
and the transitions between them. During fluorescence, the fluorophore absorbs pho-
tons exciting the electrons to an excited singlet state, and during the relaxation
process to the ground state, there is a lower energy emission of photons due to non-
radiative relaxation. Sometimes the electrons transit to the triplet excited state and
emit photons in a process called phosphorescence.
described in more detail, starting with fluorescent probes.
1.2 Fluorescent Probes
Fluorescent probes (fluorophores) are compounds that exhibit fluorescence, which is
a form of luminescence where the absorption of photons by the fluorophore excites its
electrons into a higher energy state (excited state), followed by a nearly immediate
emission of light (on the timescale of 10-8 s) [12]. For a transition to occur, the
absorbed energy must be equivalent to the difference between the electronic ground
state and the excited state. The amount of energy absorbed is characteristic for
every fluorophore and is called the excitation wavelength. During the relaxation of
the excited molecule back to the ground state, the emitted light has less energy than
the absorbed light, as some energy is lost to nonradiative relaxation (see figure 1.2).
The amount of energy emitted is also characteristic to the fluorescent probe and
is called the emission wavelength. The difference in the wavelengths of the excited
and the emitted light is called the Stoke's shift. A large Stoke's shift enables easier
separation of the excitation and emission bands, and it determines the efficiency of
5the emission signal collection. Brightness of the emitted signal also enables easier
signal collection, and it is a product of the quantum yield (F) and the absorption
coefficient (e) characteristic to the fluorophore. Quantum yield is the ratio of fluores-
cence emission to the total excitation and it enables the maximum intensity of the
fluorophore to be calculated.
Another important feature of a fluorescent probe is its lifetime. Fluorescent life-
time is an intrinsic property of the fluorophore and is defined as the length of time
between the photon absorption and the subsequent photon emission (on the order of
nanoseconds). Ideally, the fluorescent probe used for imaging has a high quantum
yield, large absorption coefficient, and large Stoke's shift with narrow emission spec-
tra in order to easily filter the desired fluorescent signal from the background and
increase SNR.
There are fundamentally two modes of excitation of a fluorescent probe: one-
photon excitation, requiring typically higher energy photons (200-500 nm range) or
two-photon excitation, utilizing lower energy photons (NIR range). Two-photon ex-
citation is a nonlinear process where two photons are simultaneously absorbed by
the fluorophore (see figure 1.3a), and the probability of two-photon absorption (2PA)
by a fluorescent molecule has a squared dependence on the excitation light inten-
sity. For a spatially uniform specimen undergoing one-photon excitation, fluorescent
signals are generated equally from each z-section above and below the focal plane
[13]. In contrast, using two-photon excitation the fluorescence signal is confined to
a femtoliter focal volume where the photon flux is maximal [13] as seen in figure
1.3b. Fluorescence excited outside the focal point volume is negligible in two-photon
excitation mode, as it falls off rapidly away from the focal volume. This property of
two-photon excitation enables generation of three-dimensional (3D) images without
the use of pinholes, by repeated scanning of the sample along the z-axis. In addition,
since a pulsed NIR laser source is used for two-photon excited fluorescence, it reduces
photodamage to the living specimen and enables deeper penetration, as mentioned
before (section 1.1). However, the biggest advantage of two-photon excitation is that
it enables high-sensitivity imaging by eliminating contamination from the fluorescent
6Figure 1.3: (a) Jablonski energy diagram, illustrating one-photon absorption (1PA),
and two-photon absorption (2PA) with subsequent emission of photons. Energy of the
emitted light (green) is lower than the energy of the excitation light (blue, red) due to
the nonradiative relaxation (black). (b) Spatial confinement of signal generation with
linear and nonlinear excitation. Visible (blueish) light is usually used for excitation
in one-photon excited fluorescence, whereas near-infrared (redish) light is used in
two-photon excited fluorescence. Fluorescent light (green) in one-photon microscopy
is equally generated from the whole volume, whereas nonlinear signal production in
2PA is localized to the focal volume [11]. (The image is a modified version from a
figure in [11].)
7light outside the focal plane [13].
Regardless of the mode of excitation, most commonly used fluorescent probes can
be divided into three categories: organic dyes, biological fluorophores, and quantum
dots. Organic fluorophores are some of the most commonly used fluorescent probes
and have first been applied in living cell imaging in the early 1900s [12]. They are
synthetic dyes whose optical properties are a function of their structure and can be
attributed to either an optical transition localized over the whole fluorophore (gen-
eral resonant transition) or to intramolecular charge transfer transitions [14]. A wide
variety of organic fluorophores have been synthesized and are small, cheap, and com-
mercially available dyes with different functionalizations ready for bioconjugation
to desired biological targets using established protocols [14, 15]. In general reso-
nant transition, fluorescent probes have narrow absorption and asymmetric emission
bands, high absorption coefficients and moderate to high quantum yields in the visible
range, but small, solvent insensitive Stoke's shifts. On the other hand, charge trans-
fer transition fluorescent probes have well-separated broad absorption and emission
bands, but small absorption coefficients and quantum yields. Unfortunately, most
of the organic dyes in the NIR range have lower fluorescence lifetime (1 ns vs. 5 ns
in visible range), limited photostability, poor thermal stability and lower quantum
yields (up to 25%), as is the case with the only NIR fluorophore approved for clinical
use, indocyanine green (ICG) [14, 7].
Biological fluorophores are fluorescent proteins that take advantage of the same
photophysics as organic dyes but are produced by cells via a cascade of DNA encoded
processes leading ultimately to fluorophore formation [7]. Similar to synthetic dyes,
there is a variety of fluorescent proteins that are commercially available, differing by
their spectral properties [16]. In comparison, fluorescent proteins have the advantage
of being genetically encodable in the organism and have the potential to be expressed
at specific locations and times during the organism's development. This allows for
minimal disruption of the organism, while enabling good visualization of target struc-
tures. Only a handful of fluorescent proteins are excited by NIR light, and in general
they have low quantum yields in the NIR range [17, 18, 16].
8The choice of organic dyes over fluorescent proteins is dependent on the imaging
needs of a particular study. Both can be selectively excited and have high sensitivity
enabling detection of a small number of targets. In addition, they can be used for
spectral multiplexing, utilizing different fluorophores that exhibit different emission
wavelengths when excited by a single light source. However, due to the nature of the
excitation and emission spectra, the number and characteristics of the fluorophores
used for spectral multiplexing are limited [14]. This is mainly because the narrow
excitation spectra, which requires excitation by light of a specific wavelength, as well
as the broad emission spectra, result in the spectra of different dyes having overlap to
a large extent. This limits the number of fluorescent probes that may be used to tag
different biological molecules and be spectrally resolved simultaneously. In addition,
other limitations that fluorescent probes exhibit are dye saturation, bleaching and
blinking.
Dye saturation is a phenomenon which occurs when the illumination of the excita-
tion light is so intense that at any time point, a significant fraction of the fluorophores
are excited to the higher energy state. As the emission of the photon is delayed by the
fluorescent lifetime of the fluorophore, the effective number of the fluorescent probes
that are excitable is effectively decreased [19, 20].
Dye bleaching encompasses all the processes that cause the fluorescent signal to
fade permanently and are due to the permanent photon-induced chemical damage to
the fluorophore [20]. There are a variety of ways that bleaching can take place, with
the most common method being associated with the relatively long-lived triplet state
(figure 1.2). When the excited fluorophore transits from the singlet to the triplet
excited state and interacts with present molecular oxygen, it can transfer some of its
energy, exciting the oxygen to its singlet excited state (forming an reactive oxygen
speciesa free radical). Free radicals can permanently destroy the fluorophore by
bleaching it. In addition, the free radicals can interact with other organic molecules
present in the cells or tissue, forming phototoxic by-products [6, 20].
Blinking (or fluorescence intermittency) is a phenomenon when a fluorophore al-
ternates between bright (on) to dark (off) states under continuous illumination.
9Dye saturation and blinking decrease the SNR as the effective concentration of flu-
orophores at any point in time is decreased, while fluorophore bleaching limits the
imaging time and such fluorophores are not suitable for long-term imaging [20, 21].
1.3 Quantum Dots
In order to address the shortcomings of organic dyes and biological fluorophores,
quantum dots (QDs) are used [3, 22]. They were first utilized as biological probes
in 1998 [23] and are now the most frequently used nanocrystal labels in bio-analysis
and medical diagnostics [14]. Quantum dots are colloidal semiconductor nanocrys-
tals ranging in size from 1 to 10 nm and consisting of hundreds to thousands of
atoms [14, 24]. Their small size is consistent with the size of macromolecules and cell
structures and is therefore of interest in biological imaging. Quantum dots generate
fluorescence when photons strike the semiconductor material, exciting the electron
from the valence band into the conduction band, leaving a hole in the valence band.
The hole and the excited electron recombine, emitting a photon with the energy equal
to that of the exciton (hole-electron pair). Since the energetic barrier between the
valence and the conduction band increases as the quantum dot gets smaller in size
(due to the quantum confinement effect), so does the energy of the emitted pho-
tons. Therefore a variety of emission wavelengths are exhibited by the same material
dependent on the size of the QDs as seen in figure 1.4.
In general, quantum dots, photophysical properties are dependent on their size,
composition, dispersity and surface chemistry [14]. In addition to the size and com-
position (as shown in figure 1.4), the emission wavelength of QDs is determined by
their polydispersity. As quantum dots are a collection of nanocrystals with slight
variations in size and shape, the emission spectrum is the sum of all of the individual
nanocrystal emission spectra, with the width of the emission spectra dependent on
the quantum dots polydispersity. In general, QDs have narrow emission with full
width at half maximum of 20-35 nm [25]. Quantum dots absorb light of all wave-
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Figure 1.4: Range of quantum dot emission wavelengths is dependent on the material
composition and the size [25]. Each of the bands represent the total range of narrow
emissions that a QD of a particular composition can be tuned to emit, with careful size
control. The wide range of emission wavelengths for different QDs enables spectral
multiplexing, and the detection and separation of emitted signals is made easier due
to the narrow emission bands for most quantum dots. (The source of the image is
[25].)
lengths lower than the emission wavelength with varying degrees of efficiency. This
broad excitation, coupled with their narrow and symmetric emission spectra allow the
same light source to be used to obtain and distinguish between a variety of signals
from different sized QDs- allowing for easier spectral multiplexing with a single light
source. In addition, their longer fluorescence lifetime, on the order of tens of nanosec-
onds, can be utilized in background autofluorescence exclusion [7]. One of the most
prominent features of quantum dots are their high quantum yields, even in the NIR
range (up to 70%), and high molar absorption coefficients (on the order of 4 times
greater than those for organic fluorescent probes) leading to very high brightness and
increased SNR [14], enabling their use in in vivo imaging with greater penetration
depths as compared to organic fluorescent probes. In addition, quantum dots have
very good photo- and thermal stability as they can be kept under intense illumination
up to hours without loss of signal brightness [24] and due to their large two-photon
cross section they can be used in two-photon excited microscopy [25]. The stability
of quantum dots is influenced by the core surface passivation [14]: through shell and
ligand coatings.
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Ligand coating of QDs is of extreme importance in biological solutions as it helps
stabilization, solubilization in desired solvent, and provides desired biocompatible
functionality for either targeting desired structures or reduction of nonspecific ad-
sorption [24]. Quantum dots can be divided into four different groups based on their
properties: core, core-shell, water soluble and bioconjugated QDs. Core QDs are
composed only of the semiconductor nanocrystals (core) that determines the optical
properties of the quantum dot. Core QDs are hydrophobic and have limited stability
and low quantum yields due to the surface defects in the crystal structure that act as
temporary ``traps'' for the electron or hole, preventing their radiative recombination
[26, 27]. Core-shell quantum dots have a passivating shell of inorganic material that
imparts these hydrophobic QDs greater photochemical stability and preserves their
brightness [25, 27]. Water soluble quantum dots are polymer-coated core-shell QDs
that enable the material to be dispersed in polar solvents, while the bioconjugated
quantum dots are coated with ligands or polymers of interest for biological systems,
like polyethylene glycol (PEG). The diverse functionality of quantum dots coupled
with their enhanced photophysical properties enables them to be the probes of choice
for the study of intracellular processes at the single-molecule level, high-resolution
cellular imaging, long-term in vivo observation of cell trafficking, tumor targeting,
and diagnostics [26, 28, 29].
However, quantum dots have similar limitations as do organic fluorescent probes.
Even though, their inorganic shells provides greater photostability and resistance
to photobleaching, the alternations between trapped an untrapped events result in
intermittent fluorescence, which limits single-molecule level imaging. There have been
advances made to address the quantum dot blinking, but they come at the expense of
broader emission spectra [30, 20]. Since quantum dots absorb photons, their signal is
saturable and SNR limiting. The most prominent limitation of quantum dots is their
inherent toxicity due to the chemical composition of QDs [31], where heavy metals
leach from the usually porous inorganic shell coating and remain a concern for chronic
toxicity [31, 32]. Research on the toxicity of quantum dots is still underway, with some
promising reported formulations of quantum dots designed for rapid renal clearance
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that could minimize in vivo toxicity [33]. Ultimately, toxicity concerns would be best
addressed with the development of nanocrystals that avoid the use of toxic metals
and functionalization methods that enable rapid clearance from the organism.
1.4 Second Harmonic Generation Probes
Another powerful tool in biological imaging is the use of second harmonic genera-
tion (SHG), which addresses some of the limitations inherent to fluorescent materials.
Second harmonic generation is a nonlinear process that relies on light scattering for
contrast generation, as opposed to fluorescence which relies on light absorption. The
theoretical groundwork explaining the process of two photon quantum transition was
first postulated by Maria Göppert-Mayer in 1931 [34]. It took 30 years until Franken
had made the first observation of SHG in a quartz crystal irradiated with a ruby laser
[35], and the first biological application in imaging of collagen in rat-tail tendon was
in 1986 [36]. SHG is a process where two identical photons of light interact with a
noncentrosymmetric material (SHG probe), occupying briefly a virtual energy state
and combining to produce a photon of exactly double the energy of incident photons
(half the incident wavelength) before returning to the ground state, exhibiting anti-
Stokes shift. To enable sufficient SHG signal production, the illumination of a highly
ordered, noncentrosymmetric material by means of an intense, focused, and pulsed
two-photon (2P) laser source is required. The optical response of the interaction of
the SHG probe with the photons is specified by the induced polarization P(w) as a
power series expansion of the electric field strength E(w):
P (ω) = χ(1)E(ω) + χ(2)E(ω)2 + χ(3)E(ω)3 + ...
where the coefficient q(n) is the nth order susceptibility of the material. First-order
susceptibility, q(1), corresponds to the linear optical responses of adsorption, scatter-
ing and reflection, q(2) and q(3) correspond respectively to second and third harmonic
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Figure 1.5: Energy diagrams describing the two-photon excited fluorescence and sec-
ond harmonic generation processes respectively [21]. Both processes are dependent
on the interaction of two photons with the material at the same time, but differ in
the manner of the transition. SHG involves a virtual transition where the material
is shortly excited to a virtual state, followed by a scatter of the combined photons
of exactly double the input energy, effectively conserving the energy for radiative re-
laxation. In two-photon excited fluorescence, the transition involves excitation of the
fluorophore electrons to an excited singlet state, followed by the emission of photons
with the frequency lower than the sum of the input frequencies due to partial energy
loss to nonradiative relaxation. (The source of this image is [21].)
generation. Only materials that have no inversion symmetry have a nonvanishing
second-order susceptibility, q(2), the magnitude of which contributes to the bright-
ness of the optical response. Therefore, SHG probes with large q(2), such as barium
titanate, zinc oxide and silicon carbide [21], make good exogenous imaging probes
producing bright SHG signal even at lower illumination intensities. SHG imaging has
also been applied in the investigation of endogenous biological structures that are
ordered noncentrosymmetrically such as collagen, microtubules, mitotic spindles, cel-
lulose and actomyosin [36, 37, 21]. However, ideally the use of single tags to generate
signal, as opposed to large biomolecular assemblies, is generally more applicable in
imaging of tissues and cells and especially for single molecule detection.
The SHG process is similar to two-photon excited fluorescence (figure 1.5) as both
require that two photons interact with the material at the same time. Therefore,
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second harmonic generation has the same benefits of utilizing NIR light, which allows
for deeper tissue penetration, and that the imaging is confined only to the focal volume
where the light intensity is sufficiently high to generate signal with minimal photo-
or thermal damage. However, unlike two-photon excited fluorescence, where some of
the energy is partially lost to nonradiative processes, during the SHG process all the
energy is conserved as the transition is virtual, which leads to enhanced photophysical
properties. Namely, the SHG process does not suffer from dye saturation, bleaching
and blinking problems as is the case with fluorescent probes, making SHG probes
excellent tools for long-term imaging with enhanced and consistent SNR as compared
to QDs or fluorescent probes. In addition, the femtosecond response time of the SHG
process enables fast and sensitive detection. The narrow band of the SHG signal,
with a full width half maximum on the order of 5 nm, enables easier separation
and distinction between a multitude of signals, effectively increasing the SNR. Even
though any SHG probe can be excited by a whole range of wavelengths of light, they
all exhibit distinct intensity profiles, enabling spectral multiplexing by comparison of
relative intensities [21] as demonstrated by Pantazis et al., in figure 1.6. The difference
in the intensity profiles stems from the resonance enhancement of the material, when
the input wavelength matches the difference between the excited and ground state of
absorption for the material [20].
The exogenous SHG probes, similar to quantum dots, are not genetically en-
codable in the biological organism and have to be introduced into the system via
injection or cellular uptake. Specific targeting of desired regions in the tissue or cell
can be achieved by surface functionalization of SHG probes as demonstrated previ-
ously [21, 38, 39]. Unlike QDs, SHG probes have been shown to be nontoxic and
noninterfering with the normal early development of zebrafish embryos when injected
in during the most sensitive single cell stage [21]. The long-term stability of SHG
probes, coupled with the square dependence of the SHG signal on the illumination
intensity, enables detection of even the weakest probes by increasing the laser power.
However, as the size of the SHG material decreases to the level comparable with
the biological macromolecules, so does the SHG signal sensitivity. For such small
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Figure 1.6: SHG intensity profiles of different exogenous SHG materials enable spec-
tral multiplexing of SHG probes. (A) Displayed are the 3D normalized SHG signal
data profiles of barium titanate (BaTiO3), zinc oxide (ZnO), and silicon carbide
(SiC) nanocrystals (signal ranging from 380 to 720 nm) generated by conventional
two-photon excitation (excitation ranging from 760 to 970 nm). Note that the SHG
signal peaks are always half the wavelength of the incident excitation wavelength.
The difference in the intensity profiles stems from the resonance enhancement of the
material when the input wavelength matches the difference between the excited and
ground state of absorption for the material. Color code: dark blue corresponds to
zero intensity and dark red corresponds to maximal intensity. (B and C) Multi-SHG
imaging modality. (B) Displayed are the normalized SHG signal spectra of BaTiO3
(upper) and SiC (lower) nanocrystals generated by tuning the excitation wavelength
to 800 nm (solid line) and 880 nm (dashed line). (C) Single confocal sections showing
comparable SHG signal intensities of immobilized BaTiO3 and SiC nanocrystals in
parallel. The noncentrosymmetric nanomaterials were sequentially excited with 800
nm (top) and 880 nm (middle), respectively. Whereas the SHG signal of SiC nanocrys-
tals is only readily detectable at 800 nm, the SHG signal of BaTiO3 nanocrystal is
visible at both excitation wavelengths. Comparison of relative intensities is sufficient
to distinguish different SHG nanoprobe materials (bottom, false-colored picture: SiC
nanocrystals in red, BaTiO3 nanocrystal in green). Scale bar: 500 nm. (The source
of this image is [21].)
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SHG probes, enhancements of the signal will likely be necessary to achieve detectable
SHG, possibly by manipulating the resonance enhancement of the probe with specific
surface coatings (e.g., with Au [40]).
In summary, the choice of an imaging probe and the process used by that probe
is dependent on the experimental needs for a particular application, and the few
presented here are by no means an exhaustive list. SHG probes, quantum dots and
fluorescent probes differ in their photophysical properties, but are complementary to
each other, offering interesting opportunities for multimodal spectral imaging. Ideally,
for biological imaging applications the probe should be biocompatible, stable long-
term, nontoxic and a strong signal emitter, which will allow for easier signal detection
and separation from the background noise. The ability of NIR light to interact with a
probe enables deeper penetration with minimal deleterious effects on the surrounding
tissue. These probes can be used in a variety of applications and can be specifically
targeted to structures of interest by different probe functionalizations.
1.5 Functionalization of Imaging Probes
In order for the inorganic imaging probes, such as quantum dots and SHG probes,
to be utilized for biological imaging applications, they require proper surface function-
alization. Particle surface interactions with the environment affect their stability and
potentially their physicochemical properties. Therefore, by deliberate surface modifi-
cations the particles can be imparted stability and possibly targeting specificity [41].
Synthesis of nanoparticles usually involves stabilizing ligands that bind to the particle
surface, stabilizing them from aggregation and aiding in the control of the growth rate
and the morphology of the particle, which can be achieved by a addition of ligands
with a greater affinity for a particular crystal facet of the nanoparticle. Preferential
binding of ligands to the crystal facets that leads to a variety of geometrical shapes
of the ZnO nanocrystals has been demonstrated [42].
However, the bonds between the inorganic nanoparticle surface and the ligand
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end groups undergo dynamic binding and unbinding processes [43]. As a consequence
of the unbinding of the surface ligands, by either extensive washing or competitive
binding with another ligand exhibiting stronger binding affinity, the particle stability
can be altered, resulting in aggregation of the nanoparticles. Therefore, the selection
of the ligand molecule is dependent on the composition of the inorganic probe, its
size, and the solvent it is dispersed in [44].
In aqueous solutions, strongly charged ligand molecules are found to stabilize the
particles for a long time, but ligand molecules that provide steric stabilization to the
nanoparticle are found to be much more resistant to high salt concentrations than
electrostatically stabilized nanoparticles [45]. One example of such steric stabiliza-
tion in aqueous solutions, which is commonly used for the application in biological
samples, is the coating of nanoparticle surfaces with amphiphilic PEG polymer [46].
Owing to its chemical stability, PEG is an inert, biocompatible polymer which has
numerous applications in medicine and biotechnology. PEGylation of nanoparticles
improves their cytoplasmic transport by minimizing the attractive forces to cytoskele-
tal elements [47]. A variety of PEG reagents are commercially available, both mono-
functional, with a methoxy group at the free end, of bifunctional varieties, which can
be used for the introduction of desired functional groups to the particle surface.
Apart from surface coating with PEG polymers, other ligands that have been used
in well establishes protocols [48] are DNA, RNA, proteins, lipids, vitamins, sugars
and enzymes [44]. Conjugation of biomolecules to inorganic nanoparticles generates
biocompatible hybrid materials, that allow the introduction of inorganic probes into
the biological specimen with targeted specificity.
In addition, the surface of inorganic particles can be coated with silane reagents.
Silanes are silicon compounds with functional or nonfunctional alkyl chains, and are
applied for adhesion enhancement, improvement of particle dispersion, crosslinking,
derivatization of functional groups, and modification of surface hydrophilicity [49].
Another common surface modification method is the use of click-chemistry, with the
use of a spontaneously occurring chemical reaction with high yield and selectivity
between the functional groups at mild conditions. These click reactions are most
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commonly performed by reacting an azide with an alkyne [50].
Regardless of the functionalization method, all chemical surface modification schemes
are dependent on the ligand shell or surface coating, and not on the actual inorganic
core material [44]. Therefore, the surface of inorganic nanoparticles can be modified
with a variety of ligands that impart nanoparticle stability by either electrostatic in-
teraction or steric hindrance, as well as desired functionality. In addition, surfaces
of nanoparticles can be coated with a number of functional groups, by varying the
concentration of the coating ligands [51].
1.6 Research Objectives
The objectives of the research presented in this dissertation are twofold. First,
in Chapter 2, the work that has been submitted for publication to Nature Proto-
cols Journal and coauthored by W. Dempsey, Dr.P. Pantazis and Dr.S. Fraser on the
novel functionalization pathways on commercial tetragonal barium titanate (BaTiO3,
referred to as BT) nanocrystals for use in a plethora of different applications is re-
ported. Commercial barium titanate crystals are polydisperse materials that have a
large second-order susceptibility, generating strong SHG signals even at low illumina-
tion intensities, and are utilized for a proof-of-principle investigation on the variety of
functionalization schemes. The model biological system used for in vivo imaging are
zebrafish due to their transparency, which allows easy optical access to cells and tis-
sues and for the zebrafish embryo being a well-established organism in cell biological
analyses of vertebrate development [52]. In addition, sensitive early embryonic ze-
brafish embryos provide a subtle test of the health of the cells during rapid division, as
any slowing in their development would indicate toxicity of the barium titanate [21].
The polydisperse nature of BT SHG probes has been a limiting factor in their appli-
cation, and an investigation on the synthesis of monodisperse non-centrosymmetric
nanocrystals was attempted. Chapter 3 describes the efforts utilized in the synthesis
of monodisperse, spherical, hexagonal zinc oxide nanocrystals, which has been shown
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to have a strong dependence on the capping agent composition and method of coating.
In the final chapter, the future direction of the functionalization of SHG nanoprobes
is proposed that should address some of the current limitations of SHG nanoprobes
mainly their signal enhancement and the wavelength of generated light.
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Chapter 2
Functionalization of Barium Titanate
Nanocrystals and Applications in
Biological Systems
2.1 Introduction
Barium titanate is a perovskite with excellent dielectric, piezoelectric and ferro-
electric properties. Bulk BT crystals exhibit noncentrosymmetric tetragonal structure
at room temperature and have been reported to elicit no toxicity in biological organ-
isms [21, 38], making them potential SHG probes for biological imaging. Indeed,
tetragonal BT is a strong SHG emitter [53, 54] and can be obtained commercially
as 200 nm tetragonal particles in powder form. Since pristine dry samples of BT
nanoparticles are strongly aggregated, surface modifications need to be performed
to help disperse and impart greater stability by overcoming the various surface in-
teractions between them. Surface modification of oxides can be achieved by either
electrostatic interaction, chemisorption or hydrophobic interaction of ligands, which
provide desired functionality, to the surface [44].
Electrostatic interactions can occur between hydrophilic particles due to the re-
pulsion of equally charged ligands on particle surfaces. These repulsive interactions
are not very stable in high ionic strength solutions due to the shielding of the electric
field, ultimately enabling attractive forces between the particles to dominate, causing
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particle aggregation. Chemisorption involves a chemical reaction between the lig-
and and the surface and is characterized by a more stable bond under a variety of
chemical conditions. Various chemical functional groups possess a certain affinity to
inorganic surfaces [44] and can be utilized for both targeted and nontargeted func-
tionalization. Previously, barium titanate surfaces have been coated with phosphonic
acid conjugated PEG [55] and polycarboxylic polymers (PAA) [56] for nontargeted
biocompatible functionalization. Targeted functionalizations of biological relevance
have also been reported for BT coated with glycol-chitosan and doxorubicin [57], and
immunoglobulin G (IgG) antibody via silane coupling [38, 21].
Applications for SHG nanoprobes in biology are wide-ranging and dependent on
the surface functionality. In general, SHG nanoprobes may be used in conjunction
with traditional exogenous and endogenous fluorescent labels as an additional unique
spectral label for multimarker imaging, such as is necessary for long-term stem cell
tracking at the level of a single cell in culture and in vivo [58]. Other applications in-
clude the use of a bolus of dispersed SHG nanoprobes as indelible markers for lineage
tracing experiments within living organisms [22], since these probes should redis-
tribute within some number of subsequent daughter cells after successive divisions
during development or regeneration, replacing or acting in conjunction with tradi-
tional dye-injection or cell transplantation strategies [59]. The benefit of the SHG
nanoprobes is that they may be especially attractive for higher-order vertebrate (e.g.,
mouse) lineage tracing or cell-tracking experiments, as their bright, high SNR signal
will be of particular interest, since these embryos become more absorptive and scatter-
ing as development proceeds past the gastrula period. The streptavidin conjugation
after biotinylation of the surface of BT will allow selective attachment to biotiny-
lated molecules for specific cell targetingsuch as receptor ligands or antibodiesas
was described previously for quantum dots [60]. The direct conjugation of antibod-
ies to the surface through covalent means would also enable specific cell labeling for
immunostaining as well as live cell targeting.
To functionalize the surface of barium titanate, we opted for the covalent attach-
ment of a linker to the surface utilizing the naturally occurring hydroxyl groups ex-
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posed on the surface of oxides. The linker of choice was N-aminoethyl-2,2,4-trimethyl-
1-aza-2-silacyclopentane for three reasons: (a) the reagent has exposed amine groups
that are readily utilized in bioconjugation with well-established reaction procedures
[48] and provide a convenient amine platform for further functionalization with a
large variety of biomolecules, (b) the covalent attachment of the linker allows for
greater stability in a variety of solvents, and (c) during the synthesis there is no
by-product formation which eliminates laborious washing procedures and minimizes
toxicity concerns. Utilizing the amine platform, a variety of chemical functionalities
have been imparted on the SHG probes and utilized for both specific and nonspecific
targeting in vivo. Similarly, the hydroxyl groups on the surface of the oxide were
utilized for the direct attachment of fluorescent probes to the surface of the BT SHG
probe, enabling potentially localized enhancement of the fluorophore signal, providing
interesting opportunities in the synthesis of novel NIR exciting and emitting probes.
2.2 Surface Functionalization and Analysis Proce-
dures
2.2.1 Amine Functionalization of Barium Titanate
In order to prepare the SHG nanoprobes for biological imaging, functionalization
is necessary to ensure biocompatibility, to achieve sufficient particle separation, and
to prevent aggregation before introduction into biological tissues. Commercial 200
nm tetragonal barium titanate nanoparticles, purchased from Nanostructured and
Amorphous Materials, with 99.9% purity, were selected as the SHG probe of choice.
To ensure the composition and the crystalline structure of the nanoparticles, powder
X-ray diffraction (XRD) analysis was performed (figure 2.1) indicating the sample
composition to be tetragonal barium titanate with no crystalline impurities present.
To prepare the surface of the BT nanoparticles for a silanization reaction with N-
aminoethyl-2,2,4-trimethyl-1-aza-2-silacyclopentane, 400 mg of commercial barium
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Figure 2.1: Powder X-ray diffraction pattern of commercial barium titanate sample.
All of the peaks on the intensity vs. 2-theta graph are assigned to barium titanate
(JCPDS 75-1606), indicating no crystalline impurities are present in the sample. The
splitting of the (002) peak at ∼44.9 2 theta degrees and (200) peak at ∼45.4 2 theta
degrees, indicated with the star, is assigned to the tetragonal P4mm symmetry.
titanate (figure 2.2a) were first sonicated with 25 mL of 30% aqueous solution of
hydrogen peroxide (H2O2) for 30 min in a Teflon flask to homogenize the dispersion.
The solution was then kept for 4 hrs at 110°C under reflux in an inert environment
to obtain a BT-OH surface (figure 2.2b). These conditions have been optimized
to saturate the surface with hydroxyl (-OH) groups as reported previously [61]. A
beneficial consequence of the H2O2 treatment is that it will strip any surface adsorbed
carbonates layer on the barium titanate, similar to the action of weak aqueous acetic
acid solutions [62]. Vacuum drying of the washed BT-OH powder using the Schlenk
line will prevent the readsorption of the carbonate layer. After hydroxylation, a 22
hr surface silanization reaction with 1% (v/v) N-aminoethyl-2,2,4-trimethyl-1-aza-
2-silacyclopentane was performed at room temperature in anhydrous toluene in an
argon filled Teflon flask (figure 2.2c). The particles were washed by centrifugation
in ethanol and water. Silane surface functionalization is achieved as a result of a
ring-opening reaction made possible by hydroxyl groups on the oxide surface. This
reaction, driven by the thermodynamically favorable formation of an oxane bond with
silicon, results in a high density monolayer formation without any by-products [63]
with amine groups exposed, referred to as the BT-NH2 surface.
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Figure 2.2: Schematic of barium titanate surface functionalization. The BT surface
(a) natively has some hydroxyl groups exposed. By exposure to the 30% aqueous
hydrogen peroxide solution, the surface of barium titanate is saturated with -OH
groups (b). To expose the amine functional groups, the favorable reaction of N-
aminoethyl-2,2,4-trimethyl-1-aza-2-silacyclopentane with the surface hydroxyl groups
is performed in anhydrous toluene for 22 hours.
To verify the presence of different functional groups on the BT surface by means
of a rapid spectroscopic technique, Fourier transform infared (FT-IR) analysis was
performed on BT, BT-OH, and BT-NH2 samples using the KBr pellet method. The
powders of BT and BT-OH samples were characterized at a concentration of 2 mg
within a 47.5 mg KBr matrix, and a BT-NH2 sample at a concentration of 3 mg
within a 49 mg KBr matrix. A few drops of the N-aminoethyl-2,2,4-trimethyl-1-aza-
2-silacyclopentane solution were deposited on an IR polymer film card and used as
a hydrolyzed reagent control for referencing the IR absorption peaks in the BT-NH2
sample (as indicated by the matching arrows in figure 2.3a). The dominant peaks in
the three BT spectra correspond to Ti-O stretch (around 550 cm-1) [64] as well as the
Ti-O bend (around 425 cm-1) [65]. The wide stretch around 3000 cm-1 in the inset of
figure 2.3b (blue line) indicates that H2O2 treatment hydroxylates the BT surface
and in conjunction with subsequent vacuum dryingis successful in eliminating the
adsorbed carbonate layer that is present in the commercial BT powder spectrum
(figure 2.3b, asterisk, the weak peak at ∼1435 cm-1 disappears after hydroxylation).
The BT-NH2 sample spectrum (figure 2.3b, red line) has Si-CH3 bands at 1260 cm-1
and 800 cm-1 from the -O-Si(CH3)2- group, along with the overlapping bands at
1130-1000 cm-1 that are characteristic of Si-O-Si groups introduced in the surface
silanization reaction [66].
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Figure 2.3: (a) As a standard for comparison to BT-NH2 an IR spectrum was taken
of a few drops of N-aminoethyl-2,2,4-trimethyl-1-aza-2-silacyclopentane coating the
surface of an IR film card. The spectrum shows the common peaks for the hydrolyzed
silane material as a control. (b) IR spectra for bare commercial BT (black line), BT-
OH after hydroxylation (blue line) and BT-NH2 (red line). Note that the stretch
for Ti-O (around 550 cm-1) and the Ti-O bend (around 425 cm-1) dominate the
spectra. Focusing on the region of the spectrum between 780 and 1500 cm-1 enables
appreciation of the peaks representing proper silane coating of the surface of BT-NH2
(red line) including the 800 cm-1 (i) and 1260 cm-1 (iii) stretches corresponding to Si-
CH3 bands in Si(CH3)2O group within the silane chemical structure as well as the
double-overlapping peak between 1100 and 1300 cm-1 (ii) corresponding to Si-O-Si
absorption. The peak in the BT-NH2 data (red line) near ∼1450 cm-1 (iv) corresponds
to contributions from the alkane groups in the chemical structure. In addition, the
1435 cm-1 stretch (asterisk, black line) that corresponds to to the adsorbed carbonate
groups is eliminated after surface hydroxylation with H2O2 (blue line). The inset
graph shows a zoom of the graphed data to better appreciate the OH stretch, which
appears after hydroxylation of the BT (blue and red lines, around 3450 cm-1). In
the BT-NH2 data (red line), a weak peak near 2960 cm-1 can also be seen, which is
also present in the silane control spectrum in panel a and is due to the alkane groups
stretching. Note that in order to better appreciate the nuances of each graph, a global
offset factor of 0.05 was added to all absorbance data and an offset factor of 0.2 and
0.4 was added to the absorbance values of the BT-OH and BT-NH2 data, respectively.
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In addition to the FT-IR analysis, transmission electron microscopy (TEM, 300
kV) images of the BT and BT-NH2 samples are shown in figure 2.4 along with the
respective energy dispersive X-ray spectroscopy (EDS) analysis for each. The TEM
samples have been prepared by a deposition of a small aliquot of the dilute solution
(∼20 mL) onto a carbon-coated Cu 200 mesh grid. The aliquot was allowed to rest for a
minute, and the excess solution was wicked away, and the grid stored aside for drying.
Differing surface morphology is apparent when comparing the bare commercial BT
(figure 2.4a) and the silane functionalized BT surface (figure 2.4b). The surface of
BT-NH2 is characterized by the presence of an amorphous layer around tetragonal-
crystalline functionalized BT (inset in figure 2.4b, dotted yellow line). Additionally,
control BT tends to cluster more tightly than the functionalized BT-NH2, where
there are clear gaps in between nearby particles. Thus, functionalization of the BT
surface reduces aggregation of the particles, achieving a more disperse solution that
can be used for introduction into biological samples. In addition, the EDS analysis
of the samples (figure 2.4c) clearly indicates the presence of silicon atoms only in the
silanated sample.
2.2.2 Biotinylation of Amine Functionalized Barium Titanate
The terminal ends of the silane layer are exposed amine functional groups (fig-
ure 2.5a) that are convenient for use in a variety of bioconjugation reactions. One
such reaction is the addition of an azide functionalized surface via 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC)/N-hydroxysuccinimide (NHS) coupling
of 6-azido-hexanoic acid. Amine-coated BT (30 mg) was dispersed in 1 mL anhy-
drous dichloromethane (DCM) and reacted with excess EDC (10 mg), NHS (10 mg)
and 6-azido-hexanoic acid (75 mg) for 4 hrs at room temperature [48]. The azido
modified BT (BT-N3, figure 2.5b) was washed by centrifugation with ethanol and
water. A small aliquot of the BT-N3 sample was dispersed by sonication in 1xPBS
and reacted overnight at room temperature in a copper-free click chemistry reac-
27
Figure 2.4: TEM images and EDS analyses confirming surface coating of BT. (a)
TEM image of nonfunctionalized BT control at 178,600x magnification as well as at
4,753,000x magnification (inset). Note the lattices representing the crystallinity of
the material, which is an essential requirement to be met for SHG. (b) BT-NH2 at
136 300x magnification and at 3,724,000x magnification (inset) showing the presence
of an amorphous layer (of variable thickness, usually ∼5nm) around the crystal parti-
cle. Note that the N-aminoethyl-2,2,4-trimethyl-1-aza-2-silacyclopentane coating is a
single layer at the outermost edge of the amorphous coat and that the thickness of the
amorphous coating may be attributed to barium leaching during hydroxylation. (c)
EDS spectra indicating the atomic composition of nonfunctionalized BT nanocrystals
(gray line) and functionalized BT-NH2 (black line). In addition to the characteristic
peaks for BT, there is a new peak in the BT-NH2 data that is specific to the presence
of Si atoms in the sample. Note that the Cu that is detected in each of the atomic
composition histograms arises from the TEM grid itself. Scale bars: 100nm (main
figures) and 5nm (insets).
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Figure 2.5: Schematic representation of the functionalization procedures to modify the
amine-coated barium titanate surface (a) with 6-azido-hexanoic acid via EDC/NHS
coupling and expose azide functional groups on the BT surface (b). Further function-
alization to exposed biotin on the surface (c) can be achieved utilizing a high yield,
copper-free click chemistry reaction of azide functional groups with cyclooctyne-PEO-
biotin.
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tion with 3 mL of 10 mM biotin-PEO-cyclooctyne [50], producing biotin-coated BT
nanoparticles (referred to as biotin-BT, figure 2.5c). The product was washed 3 times
in 1x PBS by centrifugation, and the sediment was collected.
To test for successful functionalization using the amine-coated BT surface as a
platform, it is desirable to have a straightforward method of comparison using, e.g.,
confocal and SHG imaging. The biotin-BT generated by this procedure is a rea-
sonable functionalization routine that can accomplish this goal, when conjugated to
fluorescent AF488-conjugated streptavidin. Bare BT and biotin-BT solutions in 1x
PBS were incubated in separate vials with 10 mL of 2 mg/mL AF488-conjugated strep-
tavidin for 1 hr in the dark at room temperature before being washed three times by
centrifugation. Aliquots of the solutions (200 µL) were placed in separate wells of an
8-well coverslip chamber and the solution was allowed to sediment for several minutes.
Using a Zeiss C-apochromat 40x/1.2NA W Corr M27 objective and the 34 channel
spectral detector on an LSM 710 microscope in lambda mode, signal was obtained
from particle clustersfrom 421 to 587 nm in ∼10 nm incrementsat the surface of
the coverslip upon illumination with 965 nm light from a two-photon laser source. Us-
ing an automated script, the SHG nanoprobe clusters from each well were segmented
using the SHG signal channel, since these crystals will have this characteristic signal
at 482.5 nm regardless of whether AF488-conjugated streptavidin coating exists or
not. A mask was created from segmented crystal data that had an area between 6
and 10 pixels (characteristic of larger than diffraction limited particles, which would
have greater nonsaturated AF488 signal, if the signal is present), and the mask was
used to obtain the average intensity for each wavelength increment within the spectral
band (421 to 587 nm). This value for average intensity for a given SHG nanoprobe
cluster was then normalized to its respective area in pixels. From a single spectral
scan at the coverslip after significant sedimentation, 465 SHG nanoprobe clusters in
the functionalized well and over 53 SHG nanoprobe clusters in the control well of
an 8-well coverslip imaging chamber were segmented using the SHG channel data
with a simple Matlab script. The average intensity for photons collected within each
wavelength band (10 nm increments in this case) was normalized to the size of each
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of the SHG nanoprobe clusters and was plotted in figure 2.6.
In each case, SHG signal occurs within the 480 nm wavelength bin for both non-
functionalized and functionalized BT. However, unlike the spectra for control BT,
which is negligible other than the SHG peak, signal from the BT-streptavidin-AF488
spectrum has SHG signal that colocalizes with the characteristic spectra of AF488
(emission at 521 nm). A paired T-test with unequal sample size and unequal variance
confirms that the BT and BT-streptavidin-AF488 have different spectra for the wave-
length range from 489 to 587 nm (∼10 nm increments) with high confidence (p-value
< 10-4). Thus, this is a reasonable imaging-based method to judge proper surface
functionalization of the BT surface. The multistep functinalization of BT-NH2 indi-
cates that the stable amine surface coating will be a successful platform for further
functionalization methods that generate well-dispersed BT nanoprobes for long-term
in vivo imaging, such as with PEG-BT.
2.2.3 PEGylation of Amine Functionalized Barium Titanate
Taking the functionalization a step further to enable nonreactive surface coating of
SHG nanoprobes, amine functionalized BT can be coated with carboxylic acid mono-
functional poly(ethylene glycol) (PEG-COOH, average molecular weight of 2,000 Da)
in anhydrous DCM with a similar EDC/NHS coupling reaction (figure 2.7) used for
biotin-BT synthesis. Excess PEG-COOH (30mg) was reacted with 10 mg BT-NH2
dispersed in 1 mL DCM by sonication, with 10 mg of EDC and 10 mg of NHS added.
The reaction was allowed to proceed for 4 hrs at room temperature, and the final
product was washed in ethanol and water by centrifugation, and the liquid super-
natant was discarded. PEG is a biocompatible polymer that effectively suppresses
nonspecific binding of proteins to nanoparticles [67]. Similarly, any molecular weight
of PEG can be used for the surface modification, with the most suitable molecular
weights of PEG reported in the range of 1.55 kDa [67].
To confirm the PEG functionalization of the BT nanoparticles, salt stability size
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Figure 2.6: Bare BT and biotin-BT were incubated in separate vials with AF488-
conjugated streptavidin for 1 hr before being washed three times by centrifugation.
Samples were illuminated with 965 nm two-photon light and analyzed at the surface
of the coverslip for the SHG signal at 482.5 nm and the emission from the AF488 dye.
Average normalized intensity and standard deviation (error bars) from 53 BT (gray
diamonds) and 465 BT-streptavidin-AF488 (black squares) SHG nanoprobe clusters
at each wavelength increment was plotted using Matlab. In each case, SHG signal oc-
curs within the 480 nm wavelength bin for both nonfunctionalized and functionalized
BT. However, unlike the spectra for bare BT, which is negligible other than the SHG
peak, signal from the BT-streptavidin-AF488 spectrum has SHG signal that colocal-
izes with the characteristic spectra of AF488. A pairwise T-test with unequal sample
size and unequal variance confirms that the BT and BT-streptavidin-AF488 have
different spectra for the wavelength range from 489 to 587 nm (∼10nm increments)
with high confidence (p-value < 10-4).
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Figure 2.7: Schematic representation of the PEGylation of amine-coated barium ti-
tanate surface via EDC/NHS coupling.
measurements were performed at room temperature by dynamic light scattering. For
this analysis, the hydrodynamic radius of the nanoparticles is measured in UltraPure
water for 10 min (data collected at 1 min time intervals), as well as in 1x PBS solution
for ten 1 min intervals (figure 2.8). Particles not properly polymer-coated should
display an increase in nanoparticle size when in salt solution due to the shielding
of the surface charge by the buffer ions. Dynamic light scattering analysis shows
that the PEG-BT samples have no appreciable increase in the particle hydrodynamic
diameter upon the addition of 11 mL of 10x PBS in 100 mL of solution of PEG-BT
in water at the 10 min time point, as compared to the BT control sample. Average
hydrodynamic radius of the PEG-BT sample increases from 191 to 211 nm, while
the nonfucntionalized BT samples hydrodynamic radius increases from 184 nm to
8.30 mm. Importantly, nonfunctionalized BT has widely varying size ranges when
performing dynamic light scattering analysis even in water, indicating a much wider
range of particle aggregate sizes, which is in sharp contrast to the more consistent
cluster sizes of PEG-BT samples. Therefore, from the salt stability study, where the
nanoparticles were exposed to effectively 1x PBS solution, only the PEG-BT solution
was stable as opposed to the BT control solution, as expected.
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Figure 2.8: Salt stability study on the BT and PEG-BT samples dispersed in 100
mL Ultrapure water by the measurement of the hydrodynamic diameter as a function
of time. At the 10 min time point, 11 mL of 10xPBS solution was added, to obtain
a 1xPBS solution, effectively. The average hydrodynamic diameter of the PEG-BT
particles in water is 382 nm, and in 1xPBS solution is 420 nm (corresponding to a
10% increase in size). In contrast, the average hydrodynamic diameter of BT particles
in water is 376 nm, and in 1xPBS is 16.6 mm (corresponding to a 4421% increase in
size). Note the vertical offset of 1000 nm applied to the BT graph to better appreciate
the nuances of the graphs.
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2.2.4 Antibody Functionalization of Amine Functionalized Bar-
ium Titanate
Functionalization of barium titanate with antibodies allows for specific targeting
of structures of interest within the organism. Procedures for the bioconjugation of
antibodies are well established [48] and vary by the chemistry and location of anti-
body targeting. Glycoproteins, biological molecules that contain polysaccharides, can
be modified specifically at the sugar residues to produce reactive functional groups.
One subset of glycoproteins are immunological molecules, immunoglobulin G (IgG)
antibodies, which have a Y shape and can be divided into two regions. The first
region, comprised of the arms of the Y, is the fragment of the antibody that specifi-
cally binds to the antigen and is called Fab (fragment, antigen binding) region. The
second region, comprised of the base of the Y, plays a role in the immune response
and is entitled the Fc (fragment, crystallizable) region. The polysaccharide chains in
the IgG are only found in the Fc region of the antibody, far from the active binding
sites. Therefore, by oxidizing the sugar residues on the Fc region, one can produce
reactive aldehyde groups and utilize them for site-specific conjugation of SHG probes
to the antibody, as schematically described in figure 2.9.
The general procedure used for antibody targeting is to disperse 10 mg of BT-NH2
in 0.1 M sodium phosphate 0.15 M sodium chloride buffer, pH 7.14 by sonication for
30min. The nanoparticles are reacted with 2 mg of succinimidyl 2-hydrazinonicotinate
hydrochloride (SHNH) in 100 mL anhydrous DMF for 1 hr at room temperature. The
powder was washed by centrifugation in buffer 3 times. Alexa Fluor 488 conjugated
IgG goat anti-rabbit secondary antibody was oxidized for 25 minutes with sodium
periodate NaIO4 (2.5 mg in 100 mL water, kept in the dark). Sodium sulfite was
used to quench the reaction for 5 minutes. The antibody was washed with centrifuge
membrane (3 kDa) against 0.1 M sodium phosphate buffer, 0.15 M NaCl, pH 7.14.
Hydrazine modified BT-NH2 was dispersed in 300 mL of water by sonication to which
100 mL of antibody solution was added and stirred in the dark for 2 hrs at room
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Figure 2.9: Schematic representation of the BT surface functionalization with specif-
ically targeting glycosylated IgG antibody. (a) The sugar residues on the Fc region
of the antibody are oxidized with sodium periodate. The surface BT-NH2 (b) is
modified with SHNH reagent, exposing hydrazine functional groups on the barium
titanate surface (c). The aldehyde functional groups react with hydrazine moeities
forming a specifically targeted coating on the barium titanate surface (d).
temperature. To stabilize Schifft's bases, 10 µL/mL of 5 M sodium cyanoborohydride
solution was added and stirred in the dark for 30 min at room temperature. To block
the unreacted aldehyde sites on the antibody, 50 mL/mL 1 M ethanolamine solution
was added and stirred in dark for another 30 min at room temperature. The powder
was finally washed with a centrifuge membrane (300 kDa) against buffer.
Antibody-coated BT nanoparticles were analyzed for the colocalization of SHG
signal by confocal and SHG microscopy. figure 2.10 indicates the colocalization of
fluorescent dye and SHG probe signal for all the different concentrations of AlexaFluor
conjugated IgG antibodies that were oxidized by sodium periodate and reacted with
hydrazine-coated BT. The colocalization of the SHG and fluorescent signal is stable
over the course of weeks upon storage at 4°C in 1x PBS.
2.2.5 Corrole Functionalization of Hydroxylated Barium Ti-
tanate
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Figure 2.10: Barium titanate surface was coated with AF488-conjugated IgG antibody
with varying concentrations of oxidized antibody. The samples were illuminated with
965 nm two-photon pulsed laser. The colocalization of the SHG signal at 482.5 nm
and the AF488 emitted signal at 521 nm indicate that the antibody functionalization
was successful.
The use of illumination light in the NIR region has the benefit of being less ab-
sorbed and scattered by the biological tissues. With the use of SHG probes alone,
the SHG signal detected is always one half of the input wavelength-producing light
in the visible range (anti-Stokes shift). By coating the surface of SHG nanoprobes
with dyes that are excited in the visible range and emit in the NIR range, one can
create an imaging probe capable of interacting with and emitting light in the NIR
range. This would lead to minimal losses of signal, from to the tissue interaction with
the light, for both excitation and emission. A novel imaging probe was designed by
functionalizing the barium titanate surface with corroles, a novel imaging probe was
designed.
Corroles are tetrapyrrolic molecules that are able to stabilize metal ions in higher
oxidation states and easily participate in substitution and metallation reactions, al-
lowing for synthesis of numerous corroles with varying solubility properties, making
them useful in many different applications [68]. The photophysical properties of cor-
roles are dependent on their structure as well as the chemical environment that they
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Figure 2.11: The schematic representation of the chemical reaction between the
surface hydroxyl groups on the barium titanate and the chlorosulfonyl groups on the
corrole in anhydrous DCM in an inert Ar environment.
are in. In general, corroles have a skeletal structure of corrin and can be modified
with a variety of chemical groups for different chemical applications and fluorescent
properties [69].
The method of functionalization of chlorosulfonated corroles with BT-OH nanoprobes
as shown in figure 2.11 was by the reaction of the chlorosulfonyl group with the surface
hydroxyl group, with the elimination of HCl. To achieve this, 18 mg of BT-OH was
first dried at 150°C and under a pressure of 2 mbar to eliminate any residual water on
the barium titanate surface. Upon cooling down to room temperature with inert gas
(Ar) flushing, a solution of 2,17-bis-chlorosulfonated-5,10,15(trispentafluorophenyl)corrole
in anhydrous DCM was added to the flask via cannule. The solution was refluxed
overnight under inert gas at 50°C. The sample was collected and washed three times
with DCM, once with acetone and once in water. A control experiment was performed
with 15 mg of BT-OH mixed with 5,10,15-(trispentafluorophenyl)corrole under the
same experimental conditions. Samples were analyzed for colocalization of fluores-
cence signal and SHG signal in 1xPBS. As demonstrated in figure 2.12a, the corroles
on the surface of the BT-corrole sample emit light at 670 nm when excited by two-
photon laser at 780 nm, and SHG signal is generated by the BT nanoparticle when
illuminated by 940 nm light. This colocalization of SHG and fluorescent signal was
not observed in the control sample (figure 2.12b).
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(a) BT sample functionalized with 2,17-bis-chlorosulfonated-
5,10,15(trispentafluorophenyl)corrole
(b) BT sample mixed with 5,10,15(trispentafluorophenyl)corrole
Figure 2.12: The fluorescent corrole emission utilizing two-photon pulsed laser at 780
nm (left panel) is colocalized with the SHG barium titanate nanoprobe signal from
940 nm two-photon pulsed laser illumination. Scale bar: 100 mm.
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2.3 Application in Biological Systems
The SHG probes can be incorporated in an in vivo setting using a simple method of
zygote stage injection of dispersed, PEG functionalized SHG nanoprobes. Over time,
the dramatic cell divisions and migration, that are hallmarks of early development,
cause the SHG nanoprobes to distribute within a large number of cells, and these
nanoparticles can be imaged within the developing embryo. The in vivo example
presented below illustrates the utility of the SHG nanoprobes: because of the high
signal-to-noise ratio (SNR), superior brightness, and absence of bleaching/blinking,
SHG nanoprobe labeling of cells within a biological tissue of interest will allow for
long-term imaging even within challenging (i.e., highly scattering and absorbing)
tissue environments.
In addition, barium titanate nanoparticles were conjugated with goat anti-mouse
secondary IgG antibody with an AlexaFluor488 tag and used for indirect staining
of whole zebrafish embryos that were permeabilized with Triton X detergent. The
main advantage of the indirect staining method is the flexibility in the use of the pri-
mary antibodywhich in this instance was the anti-dystrophin mouse host antibody.
Staining of the dystrophin protein is observed at both the transverse and horizontal
myosepta, which form the anterior and posterior borders of the muscle segments (my-
otomes), and divides the muscle into dorsal and ventral compartments, respectively
[70].
Barium titanate nanoparticles conjugated to rat anti-mouse CD117 (cKit) primary
antibody were used in the mouse hematopoetic stem cell uptake study. The CD117
protein is a transmembrane tyrosine-kinase receptor encoded by Kit gene which is
expressed in the stem cells and can be directly targeted by the cKit antibody or cKit
antibody conjugated BT nanoparticles (BT-cKit).
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2.3.1 Imaging SHG Nanoprobes within Living Zebrafish Em-
bryos
In order to incorporate SHG nanoprobes in vivo, a diluted dispersion of PEG-
BT was sonicated in deionized water for 30 min within a bath sonicator for greater
nanoparticle homogenization before injection. Several examples of BT imaging within
living zebrafish embryos can be seen in figure 2.13 and figure 2.14. In each of these
cases, within 5 min of sonication, zebrafish embryos are injected with 2.3 nL of PEG-
BT solution by inserting a borosilicate needle into the yolk cell of the embryo near
to or inside of the zygote cell. Though direct cell injection may be preferable to
ensure that a large number of particles is distributed into the organism, yolk cell
injection has a decreased chance of embryo lethality due to imperfect use of the injec-
tor. After yolk cell injection, cytoplasmic streaming and cell cytoplasmic connections
maintained with the yolk during cleavage stages [71] allows the nanoparticles to be
taken into the embryonic cells. After allowing the embryo to develop at 28°C for
as many as 24 hrsdepending on the desired stage of developmentembryos are em-
bedded in 0.1%-1% low melting point agarose within LabTek 2-well plates with #1
coverslip bottomscoverslip chambers. To show that SHG nanoprobes are localized
within cells of the zebrafish after yolk cell injection, various dye markers can be used
to label the cells within the embryo. 10,000 MW Dextran-AFlexa546 is a dye that
can be coinjected with the PEG-BT during the zygote injections. This is an effective
troubleshooting tool to ensure that zygote injections are successful before attempting
to image on the laser scanning microscope: after injection, embryos that have been
properly manipulated will have blastomeres that fluoresce under a mercury lamp
when using an appropriate filter cube (e.g., Zeiss filter set 43 Cy 3). Additionally,
Bodipy TR Methyl Ester or Bodipy FL C5 ceramide dyes can be incubated with
a dechorionated zebrafish embryo prior to imaging to label the cell interior or cell
membranes, respectively. Alternative methods that can also provide cellular context
to PEG-BT localization include ubiquitous or tissue-specific fluorescent protein ex-
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Figure 2.13: PEG-BT localizes and persists within cells of the developing zebrafish
embryo after zygote stage microinjection. (a) By the sphere stage of development,
scattered PEG-BT (white) can be seen within a great number of cells in the blastodisc
in this surface reconstruction projection (∼88 µm in depth) of a slightly tilted animal
pole mounted zebrafish embryo. In this case, 10,000 MW Dextran-AF546 was coin-
jected with the PEG-BT at the zygote stage to act as an injection control: properly
injected embryo cells fluoresce when illuminated with a laser around the peak exci-
tation of the AF546 dye (red channel in the surface reconstruction). (b) In a single
optical slice image of a laterally mounted sphere stage zebrafish embryo (animal pole
is toward the top right, ∼40 µm into the embryo in depth), PEG-BT (white) can be
seen within 6 Bodipy TR methyl-ester labeled cells. Note that Bodipy TR methyl-
ester was incubated with dechorionated embryos at a concentration of 100µM for 1 hr
before washing three times in egg water followed by imaging. (c) Staining with 100
µM Bodipy FL C5 ceramide for 1 hr followed by 3 washes in egg water during the
early segmentation period allows visualization of cell membrane boundaries within
the embryo to better appreciate the intracellular localization of the PEG-BT. Here,
the zebrafish was imaged at the 5 somite stage (∼12 hrs postfertilization) in a dorsal
orientation (anterior toward the top), which can be best appreciated in the bright
field channel (right image). In the left image, PEG-BT (white) can be seen within
the Bodipy-labeled membrane boundaries (green) of 9 cells in various tissue compart-
ments (notochord, somites, and neural territories of the developing brain) within a
single optical slice ∼72 µm deep within the embryo with respect to the dorsal surface.
(d) In this panel, a PEG-BT injected zebrafish was transferred from egg water to egg
water containing 1x PTU at ∼16 hrs postfertilization to prevent pigment formation.
Before imaging, the embryo was anesthetized with 0.015% Tricaine methanesulfonate
and dorsally mounted (anterior to the left, bright field in top image) using forceps
in 1% agarose with 0.015% tricaine methanesulfonate and 1x PTU. PEG-BT (white,
top and bottom images) persists within cells throughout the body of the zebrafish
even after 24 hr of development, as can be seen in this ∼48 µm maximum intensity
(starting ∼50µm in depth from the dorsal surface) projection of a 100 µM Bodipy
TR methyl-ester stained zebrafish embryo (red, bottom image). Scale bars: a-b, 100
µm; c, 50 µm; d, 300 µm.
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Figure 2.14: in vivo time-lapse imaging of PEG-BT within a zebrafish gastrula em-
bryo. The following are images from a time-lapse movie of a mid-gastrula period
zebrafish embryo mounted in an animal pole orientation using a Zeiss C-Apochromat
40x/1.20 W Korr M27 objective. First, 20 ng/µL plasmid membrane-targeted photo-
convertible fluorescent protein Dendra2 DNA and 80 ng/µL Tol2 transposase mRNA
were injected along with PEG-BT nanoprobes at the zygote stage. This DNA/mRNA
injection enables the embryo to be labeled in a mosaic mannerthat is, only a subset
of the total cells in the embryo will have a proper insertion of the plasmid DNA into the
genome by the expressed transposase protein, enabling expression of the membrane-
targetted Dendra2 protein. Three images ∼2.5 µm apart in the z-direction were taken
of the embryo for each time-point with no delay between frames, and approximately
38 sec were needed to capture each time-point. The resulting image stacks were
maximum intensity projected in the z-direction. PEG-BT (white) nanoprobes can
be seen in several Dendra2-labeled (green) as well as unlabeled cells. One diffraction
limited SHG nanoprobe can be seen within one Dendra2-labeled cell throughout the
time-lapse during epiboly migration (arrowhead), while other cells containing single
SHG nanoprobe clusters move out of the plane of view over time (white and yellow
arrows). Note that the varying sizes of the nanoprobes within the video presumably
stem from anomalous subdiffusion and molecular crowding within cell compartments
(e.g., endocytic compartments). Time-stamps: min:sec. Scale bar: 20 µm.
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pression by means of either simultaneous nucleic acid (e.g., mRNA DNA encoding a
fluorescent protein of interest) injection with the PEG-BT at the zygote stage or by
using a fluorescent transgenic zebrafish line.
By the late blastula period into early gastrulation, a number of SHG nanoprobes
are scattered within the blastodisc, the pile of cells sitting atop the yolk cell that
will eventually form the body of the zebrafish (figure 2.13a). In this case, 10,000
MW Dextran-AlexaF546 was coinjected with PEG-BT at the zygote stage at a con-
centration of ∼0.02 mg/ml to give contrast to the cells sitting atop the yolk. On
separate occasion, PEG-BT was injected into zebrafish zygote stage embryos once
again, this time without the addition of Dextran-AF-546 (figure 2.13b). figure 2.13b
depicts a zoomed in single optical section of one of the embryos at blastula stage
after a 1 hr incubation in 100 µM Bodipy TR, showing the clear intracellular lo-
calization of the SHG nanoprobes. A second PEG-BT injected embryo was allowed
to develop into the early segmentation period before staining with 100 µM Bodipy
FL C5 ceramide for 1 hr to visualize SHG nanoprobes inside membrane boundaries
within the developing somites and notochord (figure 2.13c). Even after ∼12 hrs of
development, the SHG nanoprobes are still localized and visible inside of cells of the
embryo. Note too that imaging after gastrulation is a particularly sensitive test for
toxicity. Any deleterious effect that could occur from introducing a compound that
perturbs necessary cell behaviorsrapid cell divisions, directed cell motion and re-
arrangements (e.g., convergence and extension [71])for body formation would be
magnified, possibly forestalling proper development of the organism. Though many
PEG-BT clusters can be seen in cells within the embryo, gastrulation still proceeds
to completion. SHG nanoprobes can be seen throughout the zebrafish embryo even
∼24 hrs after injection at the zygote stage (figure 2.13d). Importantly, any or all of
the numerous SHG nanoprobes within the zebrafish cells may be used to track cells in
time and space throughout any stage early development without loss of signal due to
photobleaching or blinking. To demonstrate in vivo time-lapse imaging of the SHG
nanoprobes within living zebrafish embryos, fluorescent protein and SHG nanoprobe
imaging were employed in tandem (figure 2.14). At the zygote stage, simultaneous in-
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jections of 20 ng/µL plasmid membrane-targeted photoconvertible fluorescent protein
Dendra2 DNA with 80 ng/µL Tol2 transposase mRNA were performed to label the
embryo in a mosaic manner as previously described [72, 73] along with PEG-BT. fig-
ure 2.14 shows snapshots from an ∼48 min time lapse during late-stage gastrulation,
where single SHG nanoprobe clusters can be seen within at least three Dendra2-
labeled epiblast as the cells migrate across the surface of the embryo. Note that the
two labels work well togethermosaic Dendra2 fluorescence allows visualization of
membrane dynamics and morphology, while SHG from the SHG nanoprobes enables
interrogation of intracellular dynamics and cytosolic fluidity. Additionally, several
nonfluorescent cells are presumably labeled with SHG nanoprobes and can be seen
during the time lapse, since these SHG nanoprobes move across the surface of the
embryo at similar rates similar to the other labeled cells in the image. Perhaps most
importantly, these SHG nanoprobes are high contrast labels that will not overlap in
space when labeling even adjacent cells (unlike untargeted ubiquitous cytosolic flu-
orescence, for example), so they will be especially useful for tracking colabeled cells
in time in three dimensions as the embryo develops, as well. Note that even at illu-
mination wavelengths below the tissue damage threshold (∼10 mW for cell culture
[74]), SHG nanoprobes can be seen in time with high contrast without the limitation
of bleaching or blinking.
2.3.2 Specificity of Antibody Targeting
For indirect staining of the whole ∼2.5 day post-fertilization zebrafish embryos,
goat anti-mouse secondary IgG antibody with an AlexaFluor488 tag was conjugated
to the BT surface. First, the whole mounts were fixed in 4% paraformaldehyde or
methanol-free formaldehyde (for either 1 hr at room temperature, or overnight at 4°C),
followed by blocking nonspecific binding in 1x PBS (without Ca2+/Mg2+) with the
addition of 0.1%-1% Triton X-100, 0.5%-1% bovine serum albumin (BSA) overnight
at 4°C. Additionally, the whole mounts were added 1% DMSO for greater tissue pene-
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tration. The tissue sections were reacted with a 1:1000 dilution of primary monoclonal
mouse Anti-Dystrophin (MANDRA1, Developmental Studies Hybridoma Bank) anti-
body concentrate for 90 min at room temperature. Upon washing, the tissue sections
were exposed to the IgG antibody conjugated barium titanate nanoparticles at a 1:3
dilution in the blocking solution for a 3 day incubation at 4°C. The whole mounts
were washed thrice and imaged within an hour of washing (figure 2.15a). As a con-
trol for the targeted staining, the secondary antibody (AF488 tagged goat anti-mouse
secondary IgG) solution was exposed to the tissue sections at a dilution of 2:500 in
the blocking solution for 2 hrs at room temperature (figure 2.15b).
The observed SHG and AF488 signal colocalization, left panels in 2.15a, indicates
that the secondary antibody is conjugated to the surface of barium titanate. The
emitted signals are located along the myosepta, as is clearly visible from the control
experiment (figure 2.15b). In addition, a large population of BT-Ab nanoparticles
remain stuck in the yolk, due to the lipids present (which is an unfortunate, but
expected result, since the particle size is large).
For the mouse hematopoetic stem cell uptake study of directly targeted BT-Ab
nanoparticles, first bone marrow cells were harvested from humerus and tibia bones of
two freshly killed mice. The cells were purified by affinity purification, where anti-cKit
coated magnetic beads were incubated with the cells and then run through a magnetic
column. The purified cells were split into two equal volumes, incubated in 1x Hanks
balanced salt solution: one containing a control solution of dispersed BT-OH particles,
and the other with the solution of dispersed BT-cKit nanoparticles. The cells were
incubated for 15 min on ice and spun down in a density gradient of lymphocyte
separation medium (Cellgro) to separate the cells from the BT nanoparticles that
sediment at the bottom in the Cellgro medium. The cells remain at the interface
between the Hanks balanced salt solution and the separation medium. Cells were then
fixed in 4% formalin and imaged in 8-well coverslip chambers. Eleven independent
regions on the plate for each of the two conditions (control BT-OH and functionalized
BT-Ab) were analyzed. From these 11 regions, the total number of cells on the plate
was counted by hand, as well as the total number of cells that seemed to have crystals
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(a) Specific targeting of the zebrafish myosepta with barium titanate
nanoparticles conjugated with IgG- AF488 secondary antibody
(b) Control staining of zebrafish with non-conjugated secondary an-
tibody
Figure 2.15: (a) Functionalized BT nanoprobes exposed over zebrafish tissue sections
incubated prior with 1% TritonX100 solution. Signal can be seen from the Alex-
aFluor488 tag on the secondary antibody (top left), as well as with the SHG signal
from the BT nanoprobe (bottom left) in regions along the myosepta. Bright field
image (top right) and merge of the bright field and SHG signal (bottom right). Note
the SHG nanoprobes alignment, for the most part, is along the vertical myosepta,
with a large portion of the nanoparticles getting stuck to the lipids present in the
yolk (on the left-hand side of the bright-field image). Scale bar: 50 µm. (b) Control
zebrafish targeting of dystrophin. The AlexaFluor488 fluorescence signal from the
secondary antibody not conjugated to the SHG nanoparticles (left). Bright-field im-
age (middle) merged with the fluorescent signal (right) with the yolk clearly visible.
Note that the puncta originate from the muscle-muscle junctions where dystrophin
is also expressed. The whole mount embryos are facing anterior down, ventral left in
both panels (a) and (b). Scale bar: 100 µm.
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Figure 2.16: Comparing the mouse hematopoetic stem cell uptake of cKit conju-
gated barium titanate nanoprobes (denoted as F) to the control BT-OH nanoprobes
(denoted as C), enhancement in the uptake is observed. The cell surface coverage of
18% as compared to the 11% for the control BT-OH probes. A two-tailed T-test with
unequal variance confirms that the BT-cKit and BT-OH are differently uptaken by
the cells with high confidence (p-value < 10-4).
attached: 4008 cells counted total in the control BT-OH case and 6756 cells total for
the surface functionalized BT-cKit case. Two-tailed T-test with unequal variance,
determined a significant p-value that is <<10-4 with an enhanced cell surface coverage
of 18% in the case of BT-cKit, as opposed to the 11% nonspecific cell surface coverage
for the control (figure 2.16).
2.4 Conclusion
The protocols presented in this chapter outline the general methods of BT SHG
nanoprobe functionalization, their introduction in vivo, and their imaging in tissues
and cells of a model organismzebrafish. As a platform for a plethora of possible
further chemical modifications, amine-coated barium titanate nanoparticles were gen-
erated by silanization of hydroxylated oxide surfaces with cyclic azasilane. Further
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functionalization steps, including EDC/NHS coupling to carboxylic acid functional
groups and hydrazine linkage to aldehyde groups on oxidized sugar residues on an-
tibodies, allowed barium titanate SHG nanoprobes to be coated with a variety of
ligands for both nontargeted and targeted functionalizations. The covalently bound
ligands were stable over a course of weeks and in different environments, as confirmed
by repeated colocalization of SHG and fluorescent signal, when appropriate, or by
FT-IR analysis for BT-NH2 samples. The use of BT SHG probes in in vivo allows
for long-term imaging of stable, nontoxic, biocompatible probes that are not limited
by dye saturation, dye bleaching or blinking.
The procedures presented in this chapter are not exhaustive and can be modified
for alternative functionalities or model organisms. Use of alternative biocompati-
ble polymerssuch as the poly(acrylic acid) (PAA) polymer [56]can provide an
even more widespread binding to the BT surface than monofunctional PEG, enabling
greater surface coverage. Additionally, utilizing commercially available heterofunc-
tional PEG reagents, which contain different functional groups on their ends, SHG
nanoprobe surfaces could be specifically targeted. This could be achieved by careful
selection of functional groups that posses a high affinity to the surface and surface
exposed functional, while the other functional end on the PEG polymer would be
utilized for specific targeting of biological sructures.
The biotin functionalization presented here served as a straightforward means
of gauging the success of the modification procedure by means of colocalization of
AlexaFluor488 fluorescent and BT SHG signal. However, the same biotin-BT probe
can be directly used for targeted imaging. Biotin has a high affinity for avidin and
steptavidin (KD∼10-15) proteins and the biotin-BT probes could be used for sensing
applications, among others [75, 76].
Barium titanate SHG nanoprobes have also been functionalized with fluorescent
dyes, corroles. Corroles are small molecules which can be synthesized with a variety
of functional groups attached, and thus tuned for different photophysical properties.
Corroles are especially interesting for the synthesis of novel imaging probes that can
interact with NIR light and emit photons in the NIR range as well. By careful design,
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the SHG nanoprobes will supply the visible light, needed for the corrole fluorescence
excitation. The relationship of this SHG enhanced fluorescence with respect to the
distance between the BT nanoparticle and the corrole can be investigated as a function
of the length of the intermediate linker between the two imaging probes. Therefore,
utilizing corroles with different functionalities, one can investigate the SHG enhance-
ment of the fluorescent signal as well as the photophysical properties of a variety of
different BT-corrole probes.
In general, the major limitation of the SHG nanoprobes in biological imaging ap-
plications is straightforward: in contrast to fluorescent proteins, these probes cannot
be used in applications requiring genetically encoded labeling. Additionally, since
commercially available ∼100-200 nm BT nanocrystals are the starting material for
functionalization in this protocol, applications for single molecule analysis or efficient
cell or protein targeting are limited, even when extending the protocol to targeted
labeling such as with the biotin linking chemistry. This restriction will be lifted once
efficient synthesis of monodisperse, tetragonal BT SHG nanoprobes is accomplished
with sizes comparable to currently used fluorescent probes (less than 10 nm). Current
established BT synthesis protocols in the desired size range only result in cubic (i.e.
centrosymmetric) crystal structures due to quantum confinement effects [77].
Monodispersity of SHG nanoprobes is desired for a number of reasons. Polydis-
perse nanoparticles have a wide distribution of sizes which in general limits their
application in biological systems. It has been demonstrated that the distribution of
nanoparticles in the body and their interaction with cells is greatly influenced by
the size of the nanoparticles, as well as their targeting ligand content [51]. In addi-
tion, monodisperse particles posses uniform physical and chemical properties, which
enables their easier characterization, functionalization, and ultimately application.
By controlling the size, and thus the properties of the particles, many interesting
studies can be conducted, such as determining the dependence of the SHG signal on
the size of the probe. Currently reported values of the second order susceptibilities
for different SHG nanoprobes, have been normalization over the average nanoparti-
cle volumes, introducing calculation errors due to the broad size distributions [78].
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Therefore, a fundamental study on the SHG efficiency in monodisperse nanoparticle
samples would allow greater understanding of their nonlinear optical properties. This
would allow for more sensitive multispectral imaging with SHG nanoprobes, as the
intensity of the SHG signal would be better resolved [21].
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Chapter 3
Synthesis of Zinc Oxide Nanoparticles
3.1 Introduction
Zinc oxide, ZnO, is a semiconductor material with unique catalytic, electronic,
magnetic and photonic properties [79]. Zinc oxide has been intensely utilized in solar
cells [80], sensors [81], photocatalysis [82], cosmetics and pharmaceuticals [83], UV-
light emitting devices, and textiles [84]. In addition, ZnO nanoparticles have been
utilized as imaging probes due to the broad, defect-related photoluminescence emis-
sion in the range of approximately 500-540 nm with narrow 380 nm excitation [85, 86].
Hexagonal zinc oxide nanoparticles, which is the thermodynamically stable phase of
ZnO at ambient conditions, have been used in SHG imaging [39, 86]. Hexagonal ZnO
is a good SHG probe for biological imaging, as it is a biocompatible, nontoxic material
with strong second-order susceptibility [85, 83, 87]. For high-quality imaging applica-
tions, the synthesis of uniform, monodisperse nanocrystals is of utmost importance.
There have been a variety of reported methods of synthesis of zinc oxide: solvother-
mal [88, 89, 90, 91], hydrothermal [92, 93, 94], microwave-assisted polyol [95, 96],
chemical vapor deposition [97], precipitation [98], and organometallic synthesis [99].
Many successful zinc oxide synthesis protocols have been developed for preparing
stable colloidal solutions. One particularly successful and widely used method is the
hydrolysis of Zn+2 salts in a basic alcoholic solution [89]. The size and morphology of
the nanoparticles were effectively controlled by the choice of solvent and stabilizing
52
ligands. Zinc oxide nanocrystals exhibit preferential growth along the c-axis and have
polar surfaces (slightly positively charged (0001) Zn surface and negatively charged
(0001) O surface) and nonpolar, energetically more favorable and stable (1010) and
(1120) surfaces [100]. Due to the energetic differences between differently charged
surfaces, to which polar solvent and ligand molecules could attach to, a variety of
morphologies were observed for zinc oxide particles [42, 101].
The objective of the work presented in this chapter was the synthesis of monodis-
perse ZnO particles with sizes less than 10 nm, which is comparable to the biological
macromolecules and fluorescent probes. The formation of monodisperse, colloidal
nanoparticle suspensions is governed by either degradation of bulk particles or by ag-
gregation of small ions into nanoparticles. Generally, the dispersion of bulk material,
by either mechanical grinding in colloidal mills or by ultrasonication does not lead
to extensive subdivisions, as small particles tend to reunite under the influence of
the attractive forces between the particles as well as the mechanical forces. A higher
degree of dispersion is generally obtained by an aggregation method, which involves
a supersaturated solution of precursor that precipitates into particles of desired size.
The formation of a new phase involves distinct stages: nucleation, particle growth
and termination.
3.2 Classical Nucleation Theory
In classical nucleation theory, a new phase formation occurs when the concen-
tration of the solute in the solvent exceeds the equilibrium solubility or when the
temperature is decreased below the phase transformation point. Since the Gibbs free
energy (DG) is high in solutions with solute concentration exceeding the solubility, in
order to reduce the overall energy a new phase is formed. Therefore, the driving force
for the processes of homogeneous nucleation and growth is the reduction in DG. If
the nucleation process leads to spherical particle formation, the change in the Gibbs
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free energy of formation of a new volume is
∆µv = kBT lnS, (3.1)
where S is the supersaturation, T the temperature, and kB Boltzman's constant. The
reduction in the overall energy, due to the formation of a new phase, is balanced
by the energy of introduction of a new surface. The energy of the new surface is
described by
∆µs = 4pir
2γ, (3.2)
where g is the surface energy per unit area, and r the radius. The overall energy of
the cluster is the sum of the energy contribution from the volume and the surface,
Dmv and Dms:
∆Gn = −V
vc
∆µv + ∆µs = −4pir
3
3vc
∆µv + 4pir
2γ, (3.3)
where V is the volume of the nuclei and vc is the molar volume of the cluster. There-
fore, as the precursor molecules (monomers) form the cluster by successful collisions,
the cluster grows. However, the process of cluster growth is in equilibrium with its
dissolution. There exists a critical size of the cluster that leads to formation of stable
particles (nuclei), which will continue to grow. This critical size, r*, is determined
thermodynamically as the radius of the cluster when DGnis at its maximum:
d∆Gn
dr
= 0 =
−4pir∗2
3vc
∆µv + 8pir
∗γ ⇒ r∗ = 2γvc
∆µv
. (3.4)
The energy barrier that needs to be overcome for the formation of stable nuclei is
then ∆G∗n =
16piγ3
3
(
vc
∆µv
)2
. The rate of nucleation (I) can be determined by assuming
that only monomers are attached to the growing cluster and that the processes of
attachment and dissolution of the monomer from the cluster are at a pseudo-steady
state. The rate of nucleation is dependent on the Gibbs free energy of formation of a
critical nuclei as described by
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I = Imaxe
(−∆G∗n
kBT
)
. (3.5)
Therefore, the nucleation rate increases as the supersaturation and temperature is
increased. In heterogeneous nucleation, which takes place in the presence of a for-
eign substrate, the energy barrier (DGn) for nucleation is effectively lowered and is
dependent on the contact angle between the foreign substrate and the solution.
Ideally, for the synthesis of monodisperse particles, the nucleation and the growth
processes are separated, such that the nucleation takes place abruptly followed by a
quick decrease in the solute concentration, preventing new nuclei from forming. Thus,
the solute present contribute to the growth of the nanoparticles until the concentration
of the monomers is reduced to the equilibrium concentration. The size distribution
of the particles is dependent on the growth kinetics. Particles grow as monomers
successfully collide and attached to the nuclei, where they can stay at the initial
point of contact, diffuse across the surface to a more energetically favorable position,
or detach back into the solution. The growth process, referred to as Ostwald ripening,
is governed either by the diffusion of the monomers to the particle surface or by the
surface reaction [102, 103].
The local concentration of the monomer at the surface of the particle (Cs) is
smaller than the bulk concentration of monomer in the solution (Cb) at a distance
d from the particle surface. The concentration difference is the driving force for the
flux (J) of monomer to the growing particle surface and is described by Fick's first
law in spherical geometry:
J = 4pir2D
dC
dr
=
4piDr(r + δ)
δ
(Cb − Cs), (3.6)
where D is the diffusion coefficient of the monomer and is governed by the Stokes-
Einstein equation (D = kbT
6piηr
, where h is the viscosity of the solvent), r is the ra-
dius of the particle and d the diffusion layer thickness. At the particle surface, the
consumption rate of monomers is described by a first-order reaction with the flux:
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J = 4pir2kd(Cs − Cr), (3.7)
where kd is the first-order decomposition rate, Cr is the solubility of the particle with
radius r. The flux, J, is defined as the change in number of monomers per time, and
since the number of monomers in a spherical particle of radius r is expressed as ratio
of particle volume over the molar volume vc:
J =
dN
dt
=
d
dt
(
4pir3
3vc
)
=
4pir2
vc
dr
dt
. (3.8)
Then the linear growth rate of the particle is
dr
dt
=
Jvc
4pir2
. (3.9)
At steady state the diffusion flux (equation (3.6)) equals the reaction flux (equation
(3.7)), which enables the flux to be expressed in terms of measurable parameters as
J =
4piDr2(r + δ)
rδ + D(r+δ)
kd
(Cb − Cr). (3.10)
Therefore, the growth rate of the particle is expressed as
dr
dt
=
D
r
(1 + r
δ
)vc
1 + D
rkd
(1 + r
δ
)
(Cb − Cr). (3.11)
The thickness of the diffusion layer is much greater than the radius of a nanoparticle,
therefore the ratio of r/d is close to zero. For a diffusion limited growth, where
the diffusion of monomer to the surface is the rate controlling step, the growth rate
(equation (3.11)) can be simplified as
dr
dt
=
Dvc
r
(Cb − Cr), (3.12)
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while for reaction-limited growth, the reaction rate is
dr
dt
= kdvc(Cb − Cr). (3.13)
The growth rate law is diffusion limited for many nanoparticle synthesis procedures.
Since the chemical potential of a particle increases with decreasing particle size, the
equilibrium solute concentration for a small particle is much higher than for a large
particle, as described by the Gibbs-Thompson equation [104].
The growth rate can be obtained by the application of the Gibbs-Thomson equa-
tion (considering only first-order terms) which relates the equilibrium concentration
of the particle with radius ri (Ci) with the equilibrium concentration at the flat surface
or bulk solubility (C∞):
Ci = C∞exp(
2γvc
RTri
) ≈ C∞(1 + 2γvc
RTri
), (3.14)
and solving equations (3.12) and (3.14) with appropriate boundary conditions. The
solution for the growth rate law for the mean particle radius, r, is then
r3 = r3o +
8γDv2cC∞
9RT
t. (3.15)
The last step in the particle synthesis is the termination of the particle growth.
This can be achieved either by the presence of a net charge on the surface of the
nanoparticles, or by capping the particle surface with ligands that would prevent the
successful addition of monomers [104]. Electrostatic repulsion between particles that
carry the same charge or are surrounded by an electric double layer is frequent in
polar solvents, where the ionic species in the solution can adsorb onto the particle
surface, or by dissociation of the surface ions into the medium. This method of particle
stabilization is only effective in low ionic strength solutions. An alternative method
of particle stabilization, which also imparts desired functionality, is by use of capping
ligands. The particles are capped with protective ligands by adsorption or covalent
attachment. These ligands show a physical or chemical affinity for the nanoparticle
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surface, providing a protective shell which can prevent the nanoparticle aggregation
or precursor incorporation by steric repulsion. This method of stabilization is in
general insensitive to the presence of electrolytes, and thus very desirable for use in
biologically relevant environments.
3.3 Parameters Affecting ZnO Synthesis
A widely used method of zinc oxide synthesis is the hydrolysis of Zn+2 salts in a
basic alcoholic solution. In general, the overall reaction for the nucleation of a zinc
salt can be described by the reaction: ZnX2 + 2Y OH → ZnO(s) + 2Y + + 2X− +
H2O, where X represents the anion, and Y the base cation [90]. To gain a better
understanding of the parameters that influence the physicochemical properties of zinc
oxide nanocrystals, many studies have been reported analyzing the effects of solvent,
anion composition, zinc ion concentration, water content, synthesis temperature and
capping agent on the size, morphology, and optical properties of nanocrystals. In
general, hydrothermal synthesis of ZnO, where water hydrolyzes the zinc salts, results
in rapid formation of large particles. The rate of ZnO growth is slowed down, in
solvothermal synthesis, performed usually in an n-alkanol or polyol solution. Hu et
al. have reported the importance of solvent choice in the synthesis of stable, size-
tuned, colloidal zinc oxide nanocrystals. For a series of n-alkanols, they demonstrate
that the nucleation mechanisms is independent on the solvent, while the diffusion-
limited growth rate of nanoparticles increases with increasing temperature and longer
solvent chain length, due to the influence of solvent viscosity, surface energy, and bulk
solubility of zinc oxide [90]. Similarly, Ayudhya et al. observed the effect of the alcohol
chain length on the size and morphology of nanocrystals, while the same effect was
not observed in glycol, n-alkane or aromatic solutions [101].
Li et al. have reported that the particle size of ZnO in ethylene glycol solu-
tions scales proportionally with water content [105], while Ratkovich et al. have
demonstrated that increase in the Zn+2:OH- ratio, increases the growth rate and
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the nanoparticle size [106]. The influence of anion on the Ostwald ripening of ZnO
nanocrystals was investigated by Hu et al., reporting that the growth rate (equation
(3.15)) is decreased dependent on the anion adsorption tendency toward the ZnO
surface [107].
Appropriate choice of the capping ligand is necessary for control of the nanopar-
ticle dispersity and stability. One of the major limitations of zinc oxide nanoparticles
is their poor stability in aqueous solutions, due to a high equilibrium concentration of
zinc ions in water over a wide pH range [108]. Therefore, unprotected or low binding
affinity ligand-coated zinc oxide nanoparticles tend to aggregate or undergo Ostwald
ripening in water [89]. To address the limitations of the ZnO stability, a variety of
binding ligands have been reported to enable stable aqueous dispersions of zinc oxide
nanocrystals. These include ZnO surface attachment of ester compounds [108], oleic
acid [109, 110], and polymers (polyether [111], poly(ethylene glycol) methyl ether
methacrylate (PEG-MEMA) [87], polystyrene and polymethylmethacrylate [112]).
In the following sections, the effects of temperature, Zn+2:OH- ratio and the cap-
ping agent on the properties of synthesized ZnO nanoparticles are described.
3.3.1 Temperature Effects
Following the widely used Meulenkamp synthesis of zinc oxide quantum dots by
hydrolysis of zinc acetate salt [89], zinc oxide nanoparticles were synthesized and
analyzed as SHG nanoprobes. The schematic of the hydrolysis, condensation and
nucleation processes from the zinc acetate salt is shown in figure 3.1. Zinc oxide
nuclei are formed from successive hydrolysis of zinc acetate salt in the presence of
lithium hydroxide monohydrate, and condensation of the hydrolyzed zinc ion com-
plexes (Zn(OH)x(CH3COOH)2-x). Ultimately, as the nuclei grow past the critical nu-
clei radius, they become stable nanoparticles that can continue to grow. The strong
dissociative adsorption of the acetate ions to the surface of the ZnO nanoparticles
[113] stabilizes the ZnO nanoparticles through electrostatic interactions.
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Figure 3.1: Schematic showing the hydrolysis and condensation reactions that lead
to the synthesis of the ZnO nuclei. Acetate ions strongly chelate to the Zn+2 ions and
are hydrolyzed by the LiOH base present in the solution. Successive condensation
of hydrolyzed zinc complexes leads to formation of ZnO nuclei and ultimately stable
ZnO nanoparticles.
According to the Meulenkamp synthesis of zinc oxide quantum dots, 5 mmol zinc
acetate dihydrate was dissolved in 50 mL boiling absolute ethanol. Upon dissolution,
the solution was cooled to 0°C in an ice bath. The 0°C cooled 7 mmol of lithium hy-
droxide monohydrate in 50 mL of ethanol, which was fully dissolved under sonication
at room temperature, was added dropwise to the zinc acetate solution and stored at
4°C overnight. To eliminate the excess ions, the solution of ZnO was washed with
heptane in a 2:1 (v/v) ratio. The solution was decanted and washed further with a
series of heptane/hexane washes. The washed product was resuspended in 50 mL of
ethanol by sonication.
Size and morphology of the nanoparticles was analyzed by TEM imaging, with the
deposition of an aliquot of the ZnO solution onto a 200 mesh carbon-coated Cu grid.
Excess solution from the grid was wicked away, and the TEM grid was set to dry at
room temperature. TEM analysis shows the synthesis of spherical ZnO nanocrystals
in the size range of 3 ± 1 nm (figure 3.2), which were prone to aggregation. The
crystal structure of 104°C oven-dried ZnO particles was characterized using an X-
ray diffractometer with Cu Ka (l = 15418 Å) radiation (figure 3.3). The X-ray
data showed peaks that were assigned to the hexagonal wurzite crystal structure
(JCPDS 35-1451, P63mc space group). The size of the ZnO crystals obtained by the
TEM micrographs was in good accordance with the size estimated by the Debye-
Scherrer formula of the powder XRD pattern. Taking into account the instrument
line broadening of ∼0.04 2J, the crystallite size was estimated at 4.3 nm by Debye-
Scherrer formula.
To investigate the synthesis temperature effects on the ZnO nanoparticles, Meu-
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Figure 3.2: A sample of ZnO nanoparticles, syntesized according to the Meulenkamp
method [89], was analyzed with TEM operated at 300kV. The particles are randomly
oriented and crystalline with diameters of 3 ± 1 nm and have the hexagonal wurtzite
structure. Particles are very aggregated.
Figure 3.3: X-ray diffraction pattern recorded at room temperature of commercial
ZnO particles (top), and the ZnO nanoparticles synthesized by Meleunkamp method
at 0°C (bottom). The supernatant of the zinc oxide synthesis was 104°C oven dried
prior to XRD analysis. Both patterns correspond to the hexagonal zincite phase
(space group P63mc, JCPDS 35-1451).
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lenkamp's synthesis procedure was modified, such that upon the dissolution of the
zinc acetate dihydrate salt in boiling absolute ethanol, the solution was cooled ei-
ther to 25°C or 50°C. Solutions were washed of excess ions, and deposited onto TEM
grids for analysis. Selected area electron diffraction (SAED) analysis (figure 3.4) in-
dicated that the crystallinity of nanoparticles synthesized at higher temperatures is
improved, similar to the findings previously reported [108]. ZnO nanoparticles were
dried at room temperature under vacuum in preparation for powder XRD analysis
(figure 3.5). The size of the crystallites was estimated by the Debye-Scherrer formula,
showing that the size of the nanoparticles slightly increases with synthesis tempera-
ture, with average crystallite size of 4.4 nm for 25°C synthesis temperature and 4.6
nm at 50°C. These observations are in accordance to previously reported temperature
effects on the crystallite average size [108].
3.3.2 Capping Agent Influence
Efforts to synthesize monodisperse ZnO nanoparticles, were not achieved by the
modified Meulenkamp method. Acetate stabilized zinc oxide nanoparticles were in
the desired size range, but very aggregated, as demonstrated in figures 3.2 and 3.4.
In an attempt to synthesize well dispersed ZnO, oleic acid, a common surfactant for
dispersion of nanoparticles, was utilized. Modifications to the procedure reported
by Ge et al. [114] were made, raising the synthesis temperature to 50°C in order
to enhanced the nanoparticle crystallinity. The zinc acetate dihydrate (50 mM) was
dissolved in 80 mL of ethanol heated to 70°C to which 50 mM solution of lithium
hydroxide monohydrate in 80 mL of ethanol at room temperature was added. The
solution was stirred for 1 hr at 50°C in an oil bath. Upon sonication, 0.25 mL of oleic
acid was added dropwise and sonicated for an additional 2 min. The solid sediment,
ZnO-OA, was washed by centrifugation with ethanol, acetone and water. Samples of
the solution were deposited on 200 mesh carbon-coated Cu TEM grids. As expected,
ZnO nanoparticles did exhibit a greater dispersity when capped with a longer chain
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(a) Synthesis temperature 25°C
(b) Synthesis temperature 50°C
Figure 3.4: TEM images (left) of the sub-5nm ZnO nanoparticles synthesized at a)
25°C and b) 50°C. The respective SAED patterns (right), indicate improved crys-
tallinity of nanoparticles synthesized at higher temperature. The TEM was operated
at 300 kV by C. Garland.
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Figure 3.5: Powder XRD patterns of dried ZnO samples synthesized at 25°C (red)
and 50°C (gray) temperatures. Most of the 2j peaks were assigned to the hexagonal
zincite phase (P63mc space group), while the sharp peaks, indicated with the star,
correspond to the unwashed excess zinc acetate (JCPDS 33-1464, C2/c space group).
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Figure 3.6: TEM images of oleic acid-coated ZnO nanocrystals raging in size from 3 to
7 nm. Oleic acid-coated ZnO nanoparticles exhibit improved dispersion as compated
to the acetic acid-coated ZnO nnocrystals, but large aggregates of primary crystallites
are still present in the solution. From the SAED pattern, the assignment of the ZnO
(200), (103), (110), (102), (101), (100) of hexagonal wurzite structure is determined.
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Figure 3.7: FT-IR spectra of ZnO-OA nanoparticles (top 3 spectra) with varying
amounts of oleic acid used during the synthesis (0.15, 0.10 and 0.05 mL, respectively).
Comparing the FT-IR spectra of the reagents, oleic acid and zinc acetate dihydrate
salt (bottom 2 spectra, respectively), the differences in the absorption frequencies
between the ZnO-OA samples and precursor reagents are assisted by visualizing the
dotted lines. The Zn-O vibrations, indicated by *, at 450 cm-1 are only present in the
ZnO-OA samples. The free oleic acid C=O peak at 1700 cm-1 is not detected in the
oleic acid capped samples, indicating that the presence of the C=O stretching peak
at 1575 cm-1 is due to the oleic acid being bound to the ZnO surface.
capping agent (figure 3.6), as compared with the acetate stabilized ZnO. However,
both samples contained large aggregate structures of primary ZnO crystallites. The
crystallites were assigned hexagonal wurzite structure from the d-spacings in the
SAED pattern of 2.83, 2.51, 1.92, 1.62, 1.49 and 1.39 Å, which are consistent with
the (100), (101), (102), (110), (103) and (200) reflections.
FT-IR analysis on the washed, and 50°C, vacuum dried ZnO-OA particles, in-
dicates that the oleic acid is bonded to the ZnO surface. As seen from the FT-IR
spectra (figure 3.7) of washed and dried ZnO-OA samples, with varying amounts of
oleic acid added (0.15, 0.10 and 0.05 mL respectively from the top down), the peaks
are attributed to: Zn-O vibrations (450 cm-1), COO-Zn stretching (1575 cm-1) [115],
while the C=O stretching of free oleic acid (1700 cm-1)[109, 110] was not detected.
Despite the improved dispersity of ZnO-OA nanoparticles, as compared to the acetate
ion stabilized zinc oxide (figure 3.2), the dispersion of such capped particles is limited
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Figure 3.8: Schematic representation of the radical living polymerization of PEG-
MEMA monomers on the surface of ZnO nanoparticle capped with MMA in the
presence of AIBN initiator. (The source of the image is [112].)
to hydrophobic environments, which is not desirable for most biological applications.
To address the need for a water soluble capping agent which would strongly bind
to the ZnO surface, a synthesis reported by Xiong et al. [87, 116] by utilizing a
biocompatible, FDA approved, PEG polymers was applied. The general method
of the synthesis of PEG-coated ZnO nanoparticles (PEG-ZnO) is by hydrolysis of
zinc methacrylate with lithium hydroxide in the presence of 2,2-azobisisobutyronitrile
(AIBN) and PEGmethyl ether methacrylate (PEG-MEMA, Mn = 475). The schematic
of the surface reaction is illustrated in figure 3.8.
Experimentally, 0.1 M zinc methacrylate (Zn-MAA) solution in 10 mL of ethanol,
and 0.14 M lithium hydroxide monohydrate solution with 27 mg AIBN in 10 mL
ethanol were prepared. To the Zn-MAA solution, 27 mg of AIBN and 1.5 mL PEG-
MEMA were added and vigorously stirred for 2 min at 80°C in an oil bath. The
hydroxide solution was added to the flask and allowed to stir under reflux for 1 hr. The
solution was then allowed to cool to room temperature and dialyzed against water for
a number of days using a 12-14 kDa regenerated cellulose membranes. Modifications
to the synthesis were also made by increasing the concentration of Zn+2 ions with the
addition of zinc chloride or by reduction of the PEG-MEMA that was introduced into
the solution. Samples were imaged by TEM, by depositing an aliquot of the solution
onto a 200 mesh carbon-coated Cu TEM grids. The solutions were transparent and no
visible precipitate was observed. figure 3.9 demonstrates that the method proposed
by Xiong et al. is a reproducible method for the synthesis of well-dispersed zinc oxide
nanoparticles with a narrow size distribution.
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(a) Bright field (left) and dark field (right) TEM images of ZnO-PEG nanoparticles
(b) HR-TEM image of the ZnO-PEG nanoparticles and SAED pattern
Figure 3.9: a) Bright-field and dark-field images of ZnO-PEG sample (with 0.1 M
ZnCl2 added) show that the particles are well dispersed and with a narrow size dis-
tribution range from 2 to 4 nm. b) The HR-TEM image and the SAED pattern
demonstrate that the nanoparticles are crystalline in with hexagonal crystal struc-
ture.
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Figure 3.10: TEM micrographs of ZnO solutions with varying concentrations of zinc
chloride added: 0.1 (left), 0.2 (middle) and 0.37 M (right). As the ratio of Zn+2:OH-
increases, so does the particle size.
3.3.3 Concentration of Zinc Ions and PEG-MEMA Monomer
Effects
Expanding on the Xiong et al.method of synthesis of water stable ZnO-PEG
nanoparticles [112], the effects of the concentration of zinc ions and the amount
of PEG-MEMA monomer on the properties of ZnO nanoparicles were investigated
by TEM. In general, the size of the nanocrystals increases with increasing amounts
of zinc ions present in the solution, and with the decreasing amount of PEG-MEMA
monomer added. All the samples were synthesized according to the method described
in the previous section, with the modification only in the amounts of precursors that
were added.
Zinc chloride salt was chosen as the source of zinc ions, as it has a higher solubility
as compared to zinc acetate or zinc nitrate salts. In separate experiments, 0.1, 0.2, and
0.37 M of zinc chloride were added to the 0.1 M zinc methacrylate salt solutions with
1.5 mL of PEG-MEMA added. Analyzing the solutions on the TEM, an increase in
the size of the nanoparticles is observed as the Zn+2 concentration is increased to 0.47
M Zn+2. Additionally, the morphology of the particles with the highest concentration
of Zn+2 ions present in the solution changes to a less spherical shape.
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Figure 3.11: TEM micrographs of the ZnO ethanolic solutions, where 0.1 M Zn-MAA
and 0.37 M ZnCl2 are reacted in the presence of 0.14 M LiOH in the presence of
AIBN at 80°C with decreasing amounts of PEG-MEMA monomer added: 1.5 mL
(left panel), 1.0 mL (middle panel) and 0.5 mL (right panel).
In order to investigate the effect that decrease in the amount of added PEG-
MEMA has on the size and morphology of the nanoparticles, three experimental
conditions were analyzed. The total concentration of Zn+2 ions was kept constant
at 0.47 M, and varying amounts of PEG-MEMA monomer were added, ranging from
1.5, 1 and 0.5 mL. Investigation by TEM indicates that the size and the morphology
of the crystals changes (figure 3.11). The size of the primary crystallites was similar
(∼10 nm), but the occurrence of aggregated, secondary structures increased with
decreasing amount of the PEG-MEMA. In the sample with the least amount of PEG
monomer added, in addition to well dispersed ZnO-PEG particles some aggregation
of particles was observed (figure 3.11 right panel), similar to the results obtained for
ZnO nanocrystals synthesized by the Meulenkamp method.
This can be explained by the mechanism of growth of the ZnO-PEG nanoparticles
as reported by Xiong [32] in comparison with the classical sol-gel method reported
by Meulenkamp [89] (figure 3.12). The mechanism of ZnO nanoparticle formation
by the Meulenkamp's method is by the hydrolysis of zinc salt precursor and their
subsequent condensation into nuclei large enough to be stable for continued growth.
As the stabilizing ligand on the surface of ZnO are acetate ions, over the course of
time, they dynamically bind and unbind from the nanoparticle surface, allowing the
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Figure 3.12: Schematic representation of the difference in the mechanisms of ZnO
nanoparticle formation by the Xiong method (top) and the Meulenkamp method
(bottom). (Source of the schematic is [32].)
nanoparticles to continually grow/aggregate at the expense of the smaller particles
following the Ostwald ripening law.
In contrast, the mechanism of ZnO nanoparticle formation by the Xiong method
involves nucleation of PEG-MEMA polymerized ZnO. Subsequent growth of these
PEG-ZnO nuclei leads to a formation of tightly polymer bound ZnO-PEG nanoparti-
cles. Therefore, in systems where the amount of zinc methacrylate and PEG-MEMA
monomer are optimized, the tightly bound polymer shell will prevent the from particle
aggregation. However, if the PEG-MEMA and ZnO-MAA amounts are not balanced,
particles will aggregate and precipitate out.
Therefore, decrease in the amount of PEG-MEMA monomer in the presence of
zinc chloride and zinc methacrylate salts leads to a smaller amount of PEG- ZnO
nuclei that ultimately leads to fewer and smaller ZnO-PEG particles. However, the
zinc chloride can also hydrolyze in the presence of lithium hydroxide (similar to the
Meulenkamp method) and potentially interact with the properly polymerized PEG-
ZnO nuclei to form well-dispersed, polymer bound, irregular shaped aggregates of zinc
oxide. And example of this aggregation is see in the HR-TEMmicrograph (figure 3.13)
of an aggregated particle that is well dispersed (no other crystalline particles surround
it). The orientation of the primary crystallites can be see from the lattice fringes,
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Figure 3.13: HR-TEM micrograph of a well-coated ZnO-PEG nanoparticle, which is
an aggegate of differently oriented primary crystallites. Note the arrow pointing to
the crystal that is differently oriented than the crystal in the foreground.
where the area marked with the arrow indicates the crystal oriented differently from
the crystal seen in the foreground. Similarly, a series of dark-field images (figure 3.14)
were collected at different diffraction conditions, such that the diffraction intensity is
obtained coming from only a select diffraction plane, providing insight into the crystal
orientation.
Therefore, the monodispersity of the PEG-coated ZnO nanoparticles is a a func-
tion of both the concentration of the Zn-MAA precursor, as well as the amount of
PEG-MEMA. If the concentration of the zinc methacrylate salt is increased, the poly-
merization between the adjacent precursor molecules can lead to the formation of an
network of ZnO particles crosslinked together, as seen on figure 3.15, where 0.3 M
zinc methacrylate concentration was reacted with 1.5 mL PEG-MEMA, without the
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Figure 3.14: TEMmicrographs comparing the diffraction intensity at select diffraction
planes of the particles inaged in bright field (A). The SAED pattern confirms crystal
wurzite structure (B), darf field images with: the 1stand 2nd diffraction rings (C), 3rd
and 4th diffraction ring (D), and 5th and 6th diffraction rings selected (E).
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Figure 3.15: HR-TEM micrograph of the intercrosslinking ZnO nanoparticles.
addition of any zinc chloride.
The size of the crystals is dependent on the rate of nucleation, which can be
controlled by the Zn+2:OH- ratio. For smaller Zn+2:OH- ratios, the crystal sizes will
be even smaller as the hydrolysis of the precursor would take place at a greater rate
[117]. However, for larger Zn+2:OH- ratios, the amount of PEG-MEMA monomer
needs to be optimized, to avoid particle cross-linking by the polymerization of the
methacrylate ligands on the surface of ZnO.
3.4 SHG Signal Efficiency
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Figure 3.16: ZnO-PEG nanoparticles, synthesized by Xiong method (0.1 M Zn-MAA
in presence of 1 mL PEG-MEMA and 0.37 M of zinc chloride), were imaged by
LSM 710 microscope with 800 nm laser light. At the bottom of the coverslip, only
aggregated particles show SHG signal (left). Merge of the bright field and SHG signal
(right). Scale bar: 50 mm.
The main objective of this work, was the synthesis of monodisperse ZnO nanopar-
ticles with sizes less than 10 nm, such that they are comparable in size to the biological
structures and fluorescent probes. The solutions of ZnO nanoparticles were analyzed
for the presence of SHG signal, using the LSM 710 (Carl Zeiss AG) microscope with
2-photon capabilities (Chameleon Ultra II, Coherent). As the size of the nanoparti-
cles is very small, it was expected that the SHG signal sensitivity would be decreased
from those of bulk crystals. Unfortunately, from the current setup of the LSM 710
microscope that was used, only the signals of aggregated samples at the coverslip
were detectable.
3.5 Conclusion
For imaging of highly absorbing and scattering biological samples, second har-
monic generation is utilized, due to enhanced signal properties compared to fluores-
cent probes or quantum dots. Currently, the biological imaging applications of SHG
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nanoprobes have been limited to commercially available nanopowders with wide size
distributions. Such samples do not have uniform chemical and physical properties,
and are limited in their application for single molecule analysis of protein targeting.
Therefore, to address these limitations, the synthesis of sub-10 nm SHG nanoprobes
of hexagonal zinc oxide SHG nanoprobes of was attempted.
Zinc oxide is a cheap, widely used, nontoxic material, with established synthesis
procedures as quantum dots. Most commonly, these procedures are performed by
solvothermal methods, where a zinc salt is hydrolyzed by a basic solution, and upon
condensation of the hydrolyzed precursor, ZnO nuclei are formed and continue to
grow. Particle growth is terminated upon either efficient capping of the surface of the
particle with strongly bound ligands or when the equilibrium solubility concentration
is achieved. Without the strongly bound capping ligands, particles will continue to
grow, at the expense of smaller particles, according to the Ostwald ripening rate law
[89, 32].
In order to control the size and morphology of nanoparticles, it is important to
understand the parameters that govern their growth. In this work, a variety of chem-
ical synthesis procedures were investigated and evaluated based on the properties of
the synthesized zinc oxide nanoparticles. An increase in the synthesis temperature
leads to greater crystallinity of the nanoparticles, due to the monomers having more
energy to attach or migrate to energetically more favorable positions. Synthesis tem-
perature increase also lead to larger primary crystallite sizes, due to the effects of
solvent viscosity and solubility of zinc oxide. At higher temperatures, the viscosity
of the solvent decreases and the diffusion constant of the monomer increases. Thus,
it takes less time for the monomer to diffuse to the particle surface. In addition, the
solubility of zinc oxide increases at higher temperatures and the rate of dissolution of
smaller particles is greater. Thus, larger particles will grow at the expense of smaller
ones.
A very important parameter for the synthesis of zinc oxide nanoparticles is the
ratio of the base to the zinc salts. At lower Zn+2:OH- ratios, the hydrolysis rate
is increased, which leads to formation of smaller particles. As the Zn+2:OH- ratios
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increases, larger particles can be formed as more zinc precursor is available for the
continued growth of the particles. However, the main distinction between the synthe-
sis procedures that were investigated was the capping agent. Small ligand molecules
(i.e., acetate) have a strong affinity for the polar surface of ZnO, but due to the elec-
trostatic nature of the interaction, they are not an effective ligand to use for long-term
stability in biological aqueous solutions which have a higher ionic strength. Oleic acid
has a longer hydrophobic chain, as compared to acetate, leads to the formation of
particles that are better dispersed that the acetate-capped ZnO nanoparticles are, but
in addition from not being able to completely eliminate the aggregation of particles,
they also are not easily dispersed in aqueous solutions.
Therefore, for a well-dispersed solution of zinc oxide nanoparticles, one should use
longer chain ligands that are amphiphilic and provide long-term stability to the parti-
cles. One such system was the synthesis of PEG-coated ZnO nanoparticles [32], where
the protective PEG shell is achieved by poymerization of PEG-MEMA monomers
with the zinc methacrylate salts and their subsequent hydrolysis in a basic solution
to form ZnO-PEG nanocrystals. The PEG coating is tightly bound to the surface of
nanoparticles and provides a biocompatible shell that sterically shields the surface of
ZnO from aggregation.
However, aggregation can still be detected when the PEG coating is not complete,
which would be the case if insufficient amounts of PEG-MEMA are reacted with zinc
methacrylates. Similar effects are observed if the concentration of zinc methacrylates
is increased, leading to a network of crosslinked of zinc methacrylate species. Aggre-
gate formation, as well as nonspherical morphology of the particles, was also observed
when the concentration of zinc species was increased by the addition of zinc chloride.
Therefore, careful control of the synthesis conditions and optimization of the amount
and type of capping ligand to the zinc precursor are paramount for the synthesis of
monodisperse, size-controlled nanoparticles.
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Chapter 4
Conclusion and Future Outlook
To understand the way organisms develop, to see how they are organized at the
cellular level, to track the progress of therapeutics or the location of a specific bio-
logical target in a noninvasive manner, light microscopy is a powerful tool. However,
imaging of biological samples is a challenging task, as biological tissues absorb and
scatter light, especially in the visible range. Therefore, by exciting imaging probes
with low energy NIR light, the signal loss is minimized, due to minimal absorption
and scattering of tissues in the 650-900 nm range, allowing for deeper penetration.
Many imaging probes are available, with fluorescent probes being some of the most
commonly used. Unfortunately, fluorescent probes are limited in the scope of their ap-
plication, due to the phenomena of dye bleaching, blinking, phototoxicity and signal
saturation.
To address the limitations of fluorescent probes, second harmonic generation can
be utilized. As SHG is dependent on the scattering of the illuminating light, the SHG
signal is stable over time, allowing for long-term imaging, and is easily utilized with
NIR two-photon light to generate strong signal. However, only noncentrosymmetric
materials are able to generate SHG signal. Endogenous SHG signal can be obtained
from macroscopic structures in the organism (e.g., collagen, etc.), but for imaging on
the cellular level, or for tracking of a single molecule, exogenous SHG probes need
to be used. Exogenous SHG probes are nanocrystals that have a very strong SHG
signal (large second-order susceptibility value), some of of which are barium titanate
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and zinc oxide.
In order to utilize these inorganic crystals in biological applications, they need
to be made biocompatible, stable in aqueous solutions, and functionalized for de-
sired application. To achieve this, these SHG nanocrystals can be functionalized
with a variety of biological molecules, imparting them with the desired properties.
In this dissertation, was demonstrated, on the example of commercial barium ti-
tanate nanoparticles, the potential routes of chemically modifying the surface of SHG
nanoprobes for biological applications. First, the surface hydroxyl groups were re-
acted with N-aminoethyl-2,2,4-trimethyl-1-aza-2-silacyclopentane to exposed amine
functional groups along the surface. This amine platform allows for a variety of
further chemical modifications to take place, some of which have been demonstrated
here: nonfunctional coating amphiphilic PEG polymer, attachment of biotin moieties,
attachment with antibodies for specific targeting of receptors, and attachment of flu-
orescent probes for a novel NIR imaging tool. These protocols should be adaptable
to other SHG nanoprobes that have exposed hydroxyl groups on their surface.
However, one limitation of the use of commercial powders of SHG nanoprobes is
their inherent polydispersity and aggregation. To address these issue, a synthesis of
monodisperse, sub-10 nm zinc oxide particles was investigated. Utilizing solvothermal
methods of zinc oxide synthesis, it was demonstrated that for monodisperse nanopar-
ticle synthesis, the choice of the capping agent is paramount. Utilizing the long
chain poly(ethylene glycol) methyl ether methacrylate polymer to polymerize with
the methacrylate ligands present on the surface of ZnO nanoparticles, a protective
amphiphilic shell was formed. This protective coating makes the particle stable in
biological aqueous solutions and has the potential to prolong their circulation in vivo
applications.
The detection of SHG signal from such small nanoparticles, utilizing the available
microscope setups, was challenging. The SHG signal was clearly visible in aggregate
formations, which were formed under the conditions of less-than-optimal precursor
concentrations. However, SHG signal was not readily detectable in monodisperse ZnO
nanoparticles with diameters less than 10 nm. To address this limitation, a possible
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method of resonance enhancement of the SHG signal, by gold capping of the surface
should be considered. Resonance enhancement of the SHG signal can be achieved by
formation of a thin shell of gold around the ZnO nanoparticles [118, 40]. The outside
gold shell coating could easily be functionalized with thiol functional molecules for
a desired target. The application of such small nanoparticles that exhibit detectable
SHG signal, would be ideal for many applications, for cellular and protein tracking,
membrane voltage-sensitive SHG imaging, etc.
Coating of the SHG nanoprobe surface with fluorescent dyes, as demonstrated for
commercial barium titanate nanoparticles with corroles, would enable energy trans-
fer from the SHG probe to the fluorescent dye. The advantage of this novel imaging
probe is that both the illuminating and emitted light are in the NIR range, allowing
for minimal signal loss and deeper penetration of the signal. The specificity of the
donor role of the SHG nanoprobe lies in the fact that as a scattering process, the
illumination light frequency can be tuned easily. Thus, SHG probes can be coated
with corroles that exhibit different photophysical properties, to obtain a whole range
of colors. In addition to the corrole coating, the surface of the nanoprobe could be
coated with targeting molecules. Therefore, easier recognition of the probe localiza-
tion could be achieved by simple color comparison, when a mixture of SHG probes,
each functionalized with a different corrole and functional moiety, is introduced in the
system. The parameter space that could be explored is vast, from the investigation
of the photophysical properties of different corroles, or the excitation efficiency as a
function of linker lengths (the distance between the probe and the corrole), to their
applications in biological systems. Similarly, SHG probes can be functionalized with a
variety of other linkers, specifically providing multifunctionality to the nanoparticles
for desired applications, as was demonstrated with transferritin and PEG coating on
Au nanoparticles [51].
Noncentrosymmetric, monodisperse, inorganic nanocrystals with high second-order
susceptibilities and adequate surface functionalizations have the potential for a plethora
of applications in biological imaging. As this field has only recently started to develop,
the SHG nanoprobes have a bright future ahead of them.
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Appendix A
Materials and Methods for Barium
Titanate Application in Biological
Systems
A.1 Materials
 Nanoject II nanoliter injector (Drummond Scientific Company) for embryo in-
jections
 3.5 inch borosilicate glass capillary tubes (Drummond Scientific Company)
 Needle puller (Sutter Instrument, P-2000 Laser Based Micropipette Puller)
 Intertek Listed ultrasonic cleaner (Model: CD-4800) for nanoparticle dispersion
before zygote injection
 LSM 510/710 (Carl Zeiss AG) with 2-photon capabilities (Chameleon Ultra II,
Coherent) for SHG microscopy
 Equipment for raising zebrafish and maintaining zebrafish
 Zebrafish breeding tanks and equipment for collecting zebrafish embryos. Breed-
ing tanks are plastic chambers that either have a divider that allows eggs to settle
to the bottom or have marbles at the bottom of the tank to prevent fish from eating
their embryos before collection
 Labtek multiwell chambered coverglass/coverslip chambers (Nunc International,
#1 coverslip thickness, 2- and 8-well)
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 Forceps (Student Dumont #5: Fine Science Tools)
 Hair loop (piece of hair looped and taped or glued to the end of a 2-3 mm
diameter plastic or metal rod) to orient embryos
 Glass transfer pipettes/disposable Pasteur pipets (Corning)
 Petri dishes of varying size (35x10 mm Falcon Easy Grip Petri dishes: Becton,
Dickinson and Company and 100x15 mm polystyrene disposable Petri dishes: VWR
International LLC)
 Microscope objectives with sufficient transmittance (>80%) in the UV-VIS-IR
range (Carl Zeiss AG objectives: Plan-Apochromat 20x/0.8 M27 for lower magnifica-
tion applications, LD LCI Plan-Apochromat 25x/0.8 Imm Korr DIC, C-apochromat
40x/1.2NA W Corr M27 for superficial SHG imaging within the sample, or LD C-
Apochromat 40x/1.1 W Korr UV-VIS-IR M27 for deeper imaging within the sam-
ple). CRITICAL STEP: The microscope objective used in experiments with SHG
nanoprobes should have a wide transmittance range to allow for efficient illumination
of the sample and collection of the resulting SHG signal.
 Fluorescence dissection stereomicroscope with appropriate filter sets to visualize
any fluorescent labels that were introduced along with the SHG nanoprobes (Olympus
America, MVX10 Macroview)
 Dissecting Microscope (Leica Microsystems, MZ9.5 modular high-performance
stereomicroscope)
A.2 Methods
A.2.1 Imaging Based Confirmation of Proper Functionaliza-
tion
1. Prepare a control BT solution (5 mg of BT-OH) to compare to BT-streptavidin-
AF488 following the reaction of biotin-BT with streptavidin-AF488. This will act as
a control for the extent of nonspecific binding of streptavidin-AF488 on nonfunction-
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alized particles.
2. Flick the 1.5 mL tubes several times to redisperse any sedimented BT-streptavidin-
AF488 and BT-control. Each of the solutions should be rather concentrated, so re-
move 10100 µL of the supernatant from each and dilute 1:101:100 in 1x PBS so that
the solution is milky but not completely opaque when the particles are dispersed.
3. Pipette 200400 µL of each solution into separate wells of an 8-well coverslip
chamber (#1 coverslip bottom). Note that 200 µL will be just enough for a droplet
within the well, which may make focusing to the sample easier by focusing to the
edge of the droplet, while 400 µL will fill the entire bottom of the well in solution.
4. Place the coverslip chamber on the stage of a confocal laser scanning microscope
with 2P capabilities and a spectral scanning capability (e.g., the lambda mode in the
Zeiss Zen 2009/2010 software).
5. Focus to the coverslip surface with a high numerical aperture water (since the
sample is in PBS) objective at 40x magnification.
6. Using the two-photon laser (set at 820 nm, for example) at low power (∼1% in
the software), scan single optical sections of the sample continuouslyusing a band-
pass emission filter that contains the SHG peak (peak at 410 nm, in this case)
focusing up and down in the z direction until a plane is found with the most SHG
signal (especially from the smallest SHG nanoprobes). CRITICAL STEP: SHG signal
is narrow in spectrum, so for confocal microscopes that allow direct selection of emis-
sion wavelength ranges, choose a narrow band (510 nm) centered around the peak of
SHG emission (e.g., 405415 nm or 400420 nm, when the illuminating beam is 820
nm). The choice of a narrow bandwidth filter is critical to minimize autofluorescence,
especially when imaging in biological tissues.
7. Choose a 2P wavelength that will excite the dye conjugated to streptavidin.
Note that regardless of the wavelength, SHG signal should be visible from the nanoprobes.
For BT-streptavidin-AF488, ∼965 nm is a reasonable choice to excite the AF488 dye.
8. Prepare an appropriate light path on the microscope software to detect a wide-
band of spectral information from each pixel within the image (e.g., lambda scan of a
34 channel detector in the Zeiss Zen software). Breaking up the spectral data into 10
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nm increments is sufficient, since the SHG signal will be blue-shifted and spectrally
separated with respect to the dye emission.
9. Take a single spectral scan of the plane of maximal SHG signal in the BT-
control and the BT-streptavidin-AF488 well.
10. Observe the intensity profile of the spectral data surrounding each nanoprobe
cluster within the well. The BT-streptavidin-AF488 nanoprobes should have peaks
for both SHG and AF488 emission, while the BT-control will only have the SHG
peak.
A.2.2 Zebrafish Zygote Stage Injections with PEG-BT
11. The night before embryo injections, set up male/female crosses in breeding
tanks. Separate males from females by dividers so that the fish will not breed before
the injection setup is prepared the next day.
12. Use a needle puller to prepare several injection needles made from borosilicate
glass capillary tubes. Break the end of the tip off on a bias using forceps when viewing
the tip of the needle under a dissection microscope. CAUTION: The glass pipettes
should not have an internal fiber.
13. On the day of injection (one day after step 11), prepare PEG-BT solution
for injection into zebrafish embryos. Note that depending on the application, several
preparations can be attempted: PEG-BT alone (option A), PEG-BT coinjected with
dye (option B), or PEG-BT coinjected with DNA encoding a fluorescent protein along
with transposase mRNA (option C). PEG-BT localizes within cells of the embryo
and can be tracked for any extended period of time alone. Often, it is desirable to
have cell context to the localization of PEG-BT within zebrafish cells, which can
be achieved by colabeling with PEG-BT using options B or C. Note that mRNA
encoding a fluorescent protein may be coinjected instead of fluorescent protein DNA
plus transposase mRNA, though this will not be discussed in this protocol.
(A) PEG-BT alone
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(i) Sonicate PEG-BT for 1 min in a bath sonicator. Allow sedimentation of largest
clusters for 2 min.
(ii) Dilute 1050 µL supernatant of the PEG-BT in water (UltraPure) such that
it is milky but not completely opaque (between 1:50 and 1:100).
(iii) Sonicate for 1 min in a bath sonicator.
(iv) Wait 2 minutes and then proceed with injections as described below.
(B) PEG-BT coinjected with dye
(i) Prepare PEG-BT as in steps (i)(iii) in option A.
(ii) Dilute dye to proper stock concentration using manufacturer's instructions.
For the case of 10,000 MW Dextran conjugated to an AF (in this case, AF546),
dilute to a 0.1 mg/mL injection solution in 1x PBS.
(iii) Add 1 µL of dye injection solution into 4 µL prepared PEG-BT solution and
proceed with injections as described below.
(C) PEG-BT coinjected with fluorescent protein DNA
(i) Prepare PEG-BT as in steps (i)(iii) in option A.
(ii) Prepare a plasmid by cloning the cDNA encoding a fluorescent protein of in-
terest into an appropriate vector containing transposable elements flanking the coding
region of the plasmid (e.g., pMTB vector). CRITICAL STEP: DNA injection will
allow mosaic fluorescent protein expression within a zebrafish embryo. Tissue-specific
promoter-driven expression may be used, if labeling of particular tissue types with
fluorescence is of interest. Additionally, ubiquitous promoters (e.g., b-actin promoter)
may be employed if cell-specific labeling is not needed.
(iii) Generate mRNA encoding the sequence for the transposase that recognizes
the transposable elements in the plasmid (e.g., Tol234 for the pMTB vector) by fol-
lowing the manufacturers instructions on an mRNA expression kit (e.g., mMESSAGE
mMACHINE from Ambion).
(iv) Combine the mRNA and DNA into a single stock solution for preparation for
injection. The fluorescent protein DNA concentration should be ∼100 ng/µL and the
transposase mRNA concentration should be ∼400500 ng/µL.
(v) Add 1 µL of DNA/mRNA stock to 4 µL prepared PEG-BT solution on ice
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and proceed with injections as described below.
14. It is often useful to visualize the injection into the embryo. If this is desired,
ensure that the 5 µL injection solution contains 0.1%0.3% (W/V) phenol red. A
red-colored bolus of liquid containing the injection solution should be seen in the
injected embryos when phenol red is used.
15. Remove dividers from the fish crosses that were set up the previous day so
that they will mate. Wait 1530 min for fish to mate before collecting embryos.
16. Prepare the injector setup (e.g., Nanoject II) so that the injection needle will
be within the viewing platform of a dissection microscope, and fill pipette needle with
embryo tested mineral oil before placing it on the injector itself.
17. Collect the embryos and transfer to a Petri dish filled with egg water.
18. Using a plastic transfer pipette, move the zebrafish embryos over to an agarose
injection chamber. Orient the zygote stage embryos into the grooves of the injec-
tion chamber using a forceps. Note that the chamber may be made by pouring hot
1%1.5% agarose into a Petri dish and dropping a plastic injection chamber mold (as
described in the Zebrafish book) into the center of the hot agarose until the agarose
solidifies. Remove as much liquid as possible from around the embryos.
19. Eject some mineral oil from the injector onto a small piece of parafilm under a
dissection microscope. Pipette the 5 µL of PEG-BT solution nearby on the parafilm.
Fill the needle with ∼25 µL of solution (depending on the number of embryos). Test
that the injector ejects even (2.3 nL) amounts by injecting into the mineral oil on top
of the parafilm.
20. Move the injection chamber with mounted embryos under the dissection mi-
croscope. Inject 2.3 nL of PEG-BT solution into each of the zygote stage embryos,
piercing the chorion with the needle and inserting the needle into the yolk cell just
beneath the developing zygote cell.
21. Transfer the injected embryos back into a Petri dish filled with egg water and
move the Petri dish to a 280C incubator.
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A.2.3 Preparation of Injected Zebrafish for Imaging
22. Zebrafish at different stages must be treated slightly differently to prepare
for imaging. It is discussed how to prepare samples for stages before the end of
gastrulation (<10 hr postfertilization, option A), stages after gastrulation but before
the onset of muscle twitching (∼16 hr post fertilization, option B), and stages after
the onset of muscle twitching (>16 hr postfertilization up through early larval stages,
option C).
(A) <10 hr postfertilization
(i) Transfer the embryos to a Petri dish that has been coated at the bottom with
solidified 1%2% agarose and filled with egg medium or 30x Danieau solution.
(ii) Using sharp forceps, remove the chorion from the embryos. CRITICAL STEP:
To best remove the chorion without destroying the embryo at these early stages, it
is best to tear an ever-widening hole from a single spot (using forceps in each hand)
without coming near the embryo itself. Once the hole is wide enough, rotate the
open chorion until the embryo drops out onto the surface of the agarose. Do not
allow any part of the embryo to touch the water surface or else it will be destroyed
by the surface tension.
(iii) If the embryos were prepared as in option A of step 13, staining by means
of an exogenous dye may be desirable at this stage. Prepare a labeling chamber:
coat the bottom of a small Petri dish with 1%2% agarose and let it solidify. Dilute
the desired dye to manufacturers specifications (if Bodipy TR methyl-ester or Bodipy
FL C5 ceramide, the concentration should be ∼100 µM) in 30x Danieau solution or
egg medium, and fill the labeling chamber with this solution. Carefully transfer the
embryos to the labeing Petri dish using a glass transfer pipette, again not letting the
embryos touch the water surface at any point. Stain the embryos for ∼1 hr before
transferring them back into the large agarose-coated Petri dish filled with egg medium
or 30x Danieau solution. Leave them in this solution for at least 1015 min before
the next step.
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(iv) Add 1.5 mL 0.1% low melting point agarose in egg medium or 30x Danieau
solution into one well of a 2-well coverslip chamber (#1 coverslip thickness).
(v) So that the embryos are not destroyed by the heat, let the agarose cool down
within the chamber for ∼15 min or until no condensation forms on the side of the
coverslip chamber, depending on how it was stored to keep from solidifying.
(vi) Using a glass transfer pipette, carefully transfer the embryos into the imaging
chamber, ejecting as little medium as possible along with the embryos. Under a
dissection microscope and using a hair loop (or a forceps, if you are careful), orient
the embryos so that their animal pole is touching the surface of the coverslip or such
that they are laterally mounted and sitting just above the surface of the coverslip.
CAUTION: If the yolk cell touches the coverslip, the embryo may be damaged, which
could interfere with proper development.
(vii) Let the agarose solidify around the embryos for ∼5 min before imaging.
(B) ∼1016 hr postfertilization
(i) After bud stage, the embryos are much easier to manipulate without destroying
them. Within a Petri dish filled with egg water, dechorionate the injected embryos
with sharp forceps.
(ii) If an exogenous counterstain is desired, repeat step (iii) of option A, though
this time much less volume is necessary. Just incubate the embryos within a 1.5 mL
tube at 280C in dye solution for ∼1 hr. Wash the embryos several times in egg water.
CRITICAL STEP: Regardless of the stage, once the embryos have been dechorion-
ated, only transfer them to the various solutions using a glass transfer pipette. The
embryos will stick to plastic transfer pipettes.
(iii) Add 1.5 mL 0.5%-1% low melting point agarose in 30x Danieau solution or egg
medium into one well of a 2-well coverslip chamber (#1 coverslip thickness). Allow
the agarose to cool as in step (v) of option A.
(iv) Using a glass transfer pipette, transfer the embryos into the imaging chamber,
ejecting as little medium as possible along with the embryos. Under a dissection
microscope and using forceps (or hair loop, if desired), orient the embryos in any
desired orientation (e.g., dorsal or lateral).
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(v) Let the agarose solidify around the embryos for ∼5 min before imaging.
(C) >16 hr postfertilization
(i) If imaging will be performed after 16 hr postfertilization, transfer the embryos
to a Petri dish with egg water containing 1x PTU and replace this solution at least
once daily to prevent significant pigment formation. CAUTION: PTU is a toxic chem-
ical, so wear appropriate personal protective equipment (gloves, protective eyewear)
and handle with caution.
(ii) Dechorionate injected embryos with sharp forceps. Avoid accidental trauma
to the embryo as it twitches within the chorion.
(iii) If an exogenous counterstain is desired, repeat option B, step (iii), though
make sure there is 1x PTU in the solution to prevent pigment formation during
staining. Just incubate the embryos within a 1.5 mL Eppendorf tube at 280C in dye
solution containing 1x PTU for ∼1 hr. Wash the embryos several times in egg water
containing 1x PTU.
(iv) Anesthetize the zebrafish by transferring the embryos to a Petri dish with egg
water containing 0.015% tricaine methanesulfonate along with 1x PTU.
(v) Add 1.5 mL 0.5%-1% low melting point agarosewith 0.015% tricaine methane-
sulfonate and 1x PTUin 30x Danieau or egg medium solution into one well of a
2-well coverslip chamber (#1 coverslip thickness). Allow the agarose to cool as in
step (v) of option A.
(vi) Using a glass transfer pipette, transfer the embryos into the imaging chamber,
ejecting as little medium as possible along with the embryos. Under a dissection
microscope and using a forceps (or hair loop, if desired), orient the embryos in any
desired orientation (e.g., dorsal or lateral).
(vii) Let the agarose solidify around the embryos for ∼5 min before imaging.
A.2.4 Imaging SHG Nanoprobes within Living Zebrafish Em-
bryos
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23. Place the coverslip chamber on the stage of a confocal laser scanning micro-
scope with 2P capabilities and a spectral scanning capability (e.g., lambda mode in
the Zeiss Zen software).
24. Focus into the sample using the oculars of the microscope in visual mode using
an objective of appropriate magnification andpreferably to maximize SHG signal
collectionhigh numerical aperture (≥0.8).
25. Prepare imaging settings for SHG signal collection, referred to as the SHG
channel. Prepare the emission filter band as in step 20.
26. Depending on the counterstain used, prepare imaging settings for those par-
ticular dyes/fluorescent probes in a separate channel from the SHG collection. Note
that a single channel may be used with the 2P laser alone in certain cases: many
newer laser scanning microscopes allow direct selection of emission wavelength ranges
(e.g., Zeiss QUASAR detectors), which is ideal for SHG imaging in conjunction with
fluorescent markers, since the illuminating beam for SHG can be tuned to a particular
wavelength (using a tunable 2P laser), allowing collection of two-photon fluorescence
emission simultaneously with SHG signal in two separate detectors.
27. Using low power (∼1% of maximum in the software), scan an optical section
within the tissue using the SHG channel. Larger particle clusters should be saturated
even at low power, whereas smaller clusters may require higher illuminating power,
especially if the illuminating beam is off resonance (i.e. significantly red-shifted from
800 nm, in the case of BT).
28. Increase the power until the smallest SHG nanoprobe clusters are visible
while ensuring that there is no phototoxicity to the tissue. Set up time-lapse imaging
settings with sufficient time resolution so that each of the SHG nanoprobes can be
tracked in time and space within the embryo. For example, during the gastrula
period, cells are very dynamic, so a relatively short time (on the order of a few
minutes) between frames will be necessary to track the SHG nanoprobes, assuming
they are concentrated within the embryo.
29. If multiple imaging times are desired between different stages of development,
the embryo may be removed from the agarose carefully with forceps and kept in a
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28ºC incubator in egg water until the next imaging period. Note that during the
larval stages of development and later, significant pigment formation can occur even
in the presence of PTU. Spectral detection (e.g., with the lambda mode software) can
be used to separate SHG signal from broad-band emission from different pigments
within the fish. Additionally, fish without pigment (e.g., Casper zebrafish) may also
be considered when designing an experiment using SHG nanoprobe labels.
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